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Abstract

The placenta is an active immunologic organ, modulating the maternal environment to support
the conceptus. Fetal trophoblasts produce a variety of products including pregnancy-associated
glycoproteins (PAGs) and extracellular vesicles called exosomes. PAGs directly interact with the uterus
and maternal immune cells with low concentrations correlating with adverse pregnancy outcomes in
cattle. Exosomes contain nucleic acids and proteins that influence intercellular communication during
pregnancy. The specific objectives of this body of work were to 1) quantify circulating PAG
concentrations, 2) characterize the profiles of circulating exosomal proteins and miRNAs in pregnant and
non-pregnant sheep, and 2) determine the difference in exosomal content profiles between non-infected
and BVDV-infected pregnant and non-pregnant sheep. Twenty-four yearling ewes, found to be negative
to BVDV on serum neutralizing antibody serology, were enrolled in this study. Ewes were inoculated
with BVDV NY-1 or sham media. Fifteen days post inoculation, all animals underwent hysterectomy and
peripheral blood collection. PAG1 concentrations were quantified using commercially available ELISA.
Exosomes were isolated using ultracentrifugation and gradient density separation. Small RNA high
through-put sequencing and mass spectroscopy proteomics were performed. BVDV infection status was
determined with BVDV PCR of fetal tissue, IHC of placentomes, and VN of dams. Statistical differences
between circulating concentrations of PAG1, miRNAs, and proteins were analyzed by analysis of
variance for repeated measures. PAG1 concentrations in maternal blood differed between treatment
groups, with mean concentrations significantly lower (P =0.04) in BVDV inoculated dams compared to
controls. Sixty million reads, identifying 1634 miRNAs were identified following high-throughput
sequencing. Several miRNAs were identified to be unique to BVDV exposure and pregnancy status.
With a confidence rate of 0.01, 539 proteins were identified with differential relative abundance between
viral exposure. In conclusion, infection with BVDV decreases PAG1 concentration in maternal
circulation in pregnant sheep compared to healthy controls. Exosomes containing select miRNAs and
proteins are present in peripheral circulation likely have a biological role in fetal-maternal interactions
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important in times of both disease and health. Maternal PAG concentrations and differential exosome
content may be a viable biomarker to determine placental health following reproductive viral infections.
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Chapter 1
Introduction

1

The placenta is essential for development of the fetus and maintenance of pregnancy. Cellular
communications between maternal and fetal tissues are critical to create an intrauterine environment
acclimated for fetal survival. Successful pregnancy requires modulation of the maternal immune system
by placental and endometrial production, among many other needs. Dysfunction of maternal-fetal
communication can contribute to detrimental effects and mortality of the fetus during times of
reproductive pathology induced by pathogens. In this review, an overview of placental physiology and
immunity during health and disease conditions will be presented. Biogenesis and function of exosomes
and corresponding miRNA and protein content and their significance associated with pathologic
pregnancies is summarized.
1. Placenta form and function in sheep
The placenta is a transient, yet critical organ responsible for maintenance of pregnancy and
preparation for lactation following parturition. Additionally, the placenta supports the developing fetus
by allowing nutrient exchange and immunologic protection. Both fetal and maternal components make
up the formed placenta. Description of the placenta is based on two criteria: 1) histologic separation
between maternal and fetal blood and 2) anatomical distribution of villus attachment. The ruminant
placenta is classified as synepitheiochorial with cotyledonary attachment that develops during
embryogenesis (Spencer & Bazer, 2002). Following fertilization, the sheep embryo enters the uterus by
day 3 of gestation and through mitotic development of the zygote a blastocyst forms, which is comprised
of cells required for extraembryonic membrane formation (Bazer, 2012; Sherer & Abulafia, 2001). Prior
to implantation, the extraembryonic membranes consist of the yolk sac, chorion, amnion, and allantois
(Clemente et al., 2009; Senger, 2004). The yolk sac derived from the primitive endoderm, is transient and
regresses with conceptus development, yet its lasting contribution are the germ cells lining the genital
ridge in the embryo (Senger, 2004). The trophectoderm, comprised of mononuclear trophoblast cells,
along with the mesoderm give rise to the chorion. Combination of the trophoblasts and endoderm forms
the fluid filled amnion immediately surrounding the developing fetus. The allantois, an invagination of
the primitive gut, forms to collect liquid waste originating from the embryo. Eventually the chorion and
2

allantois will fuse, forming the fetal portion of the attaching placenta (Senger, 2004). Interdigitation of
the fetal chorionic cotyledon with the maternal caruncular regions begins at 16 days following
fertilization with attachment of the embryo occurring around 18 days (Stewart et al., 1992). The
trophoblast of the developing conceptus produces interferon-tau (IFNT), which serves as the signal for
maternal recognition of pregnancy (Reynolds et al., 2015; Spencer & Bazer, 2002). INFT achieves this
function by inhibiting endometrial oxytocin receptors which in-turn inhibits estrogen receptors and
prostaglandin F2-alpha (PGF2α) synthesis (Martal et al., 1997; Spencer & Bazer, 2002). Without the
luteolytic activity of PGF2α, the ovarian corpus luteum continues to produce progesterone, the hormone
required for maintenance of pregnancy.
Epitheliochorial placenta, the least intimate of placenta types, has three intact maternal tissue
layers and three fetal layers, 6 in total separating maternal and fetal blood. However, ruminants’
epitheliochorial placenta erodes into the maternal endometrium allowing access to maternal circulation by
the invading fetal chorion (R. M. Wallace, Pohler, Smith, & Green, 2015). This placental feature of
endometrial erosion defines the synepitheiochorial placenta type found in ruminants. Two trophoblast
populations histologically comprise the developing synepitheiochorial ruminant placenta: binucleated
giant and mononuclear trophoblasts. Giant binucleated cells arise from mononuclear trophoblasts at 2
weeks of gestation in sheep (Grazul-Bilska et al., 2011). The binucleated trophoblast migrate through the
chorionic microvillar junction eventually fusing with maternal uterine epithelium forming multinucleated
fetal-maternal syncytial cells (R. M. Wallace et al., 2015). In cattle, these syncytia are transient and
disappear by day 40 of pregnancy. Yet in small ruminants (sheep and goats), these syncytia persist
throughout gestation (R. M. Wallace et al., 2015). Villous chorionic cotyledons interdigitate with
aglandular maternal uterine caruncles creating regions of fetal-maternal interaction in the form of
placentomes (R. M. Wallace et al., 2015). Direct engagement with maternal tissues is unique to the
ruminant placenta compared to other epitheliochorial placenta. By gestational day 30, placental
attachment is well established (Senger, 2004). In ewes, the placentomes form a concave structure that
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will increase in surface area throughout fetal development thus increasing nutrient exchange to keep up
with fetal growth demands.
Cotyledons are discrete button-like structures that contain abundant amounts of blood supply. As
mentioned above, the surface are of these structure increase through pregnancy, increasing the possibility
for maternal-fetal interactions. The endocrine activity of the placenta increases with fetal development as
well and placentally produced hormones gain access to both maternal and fetal compartments (Reynolds
et al., 2015). The gestation length in the ewe is approximately 150 days; binucleate trophoblasts begin
producing progesterone following 2 weeks of gestation. By gestational day 50-75 in sheep, the placenta
overtakes the ovarian corpus luteum, making the majority of progesterone needed to maintain pregnancy
until parturition (Reynolds et al., 2015; Wathes et al., 1996). After this time, luteolytic agents (i.e.
PGF2α), whether endogenous or exogenously derived, are unlikely to induce abortion alone. The high
concentration of placentally produced progesterone also blocks myometrium contractility preventing fetal
expulsion (Spencer & Bazer, 1995). Furthermore, high progesterone concentration aids in increased blood
supply to the uterus needed for the developing (Spencer & Bazer, 2002). Binucleated trophoblast also
create many other products including pregnancy-associated glycoproteins (PAGs), placental lactogens,
and prelatic-related proteins. These trophoblast-expressed proteins are delivered to the maternal uterine
connective tissue through secretory granules. All of these products can reach maternal blood circulation
as verified by positive measurements in maternal blood (R. M. Wallace et al., 2015). The exchange of
these proteins does not necessarily go both ways. In epitheliochorial, endometrium proteins and lipids do
not cross the placental barrier into the fetal compartment (Bairagi et al., 2016). Instead, the maternal
tissues utilize other forms of cross talk with the fetal placenta in the forms of extracellular vesicles
(described below).
2. Pregnancy Associated Glycoproteins (PAGs)
PAGs are placental products abundantly expressed by even-toed ungulates, such as ruminants
(Telugu, Walker, & Green, 2009). PAGs are subdivided into ‘ancient’ or ‘modern’ groups based on
phylogenetic origination (Hughes, Green, Garbayo, & Roberts, 2000). Individual PAGs are further named
4

numerically based on series of which they were sequenced or location on gene loci (R. M. Wallace et al.,
2015). Cattle and sheep, belonging to the suborder Ruminantia produce a larger concentration of
‘modern’ PAGs compared to ‘ancient’ PAGs. Two dozen PAG genes, encoding for corresponding
proteins, have been identified in the bovine and ovine genome (Telugu et al., 2009). PAGs can be
expressed in both mononuclear and giant binucleated trophoblast (R. M. Wallace et al., 2015). PAG
antibodies are identified via western blot in day 16 bovine conceptus, prior to binucleated trophoblast
formation. Immunolocalization studies have identified that modern PAGs are more abundant in
cotyledons compared to the intercotyledonary chorion. Conversely, ancient PAG transcripts are elevated
at intercotyledonary areas (R. M. Wallace et al., 2015). Numerically annotated, individual PAGs are
produced by different trophoblasts; for example, PAG-1 is produced by binucleate trophoblasts, while
PAG-2 is produced by both bi- and mono-nuclear trophoblasts (de Sousa et al., 2003; Garbayo et al.,
2000). Their expression undergoes spatial and temporal patterns through gestation, yet little is known of
how PAG gene transcription is regulated. Circulating PAG concentrations in maternal blood can be
influenced by maternal factors (i.e. weight, parity, breed), and fetal factors (i.e. birth weight, sex, number)
(Mercadante, Ribeiro, Risco, & Ealy, 2016). Circulating PAG concentrations are increased in twin
pregnancies in cattle likely due to increased production that would parallel increased total binucleate
trophoblast numbers (Garcia-Ispierto et al., 2013).
PAGs produced by binucleated giant cells and secreted at the maternal uterine stroma are the
basis of blood & milk pregnancy tests in ruminants. PAGs have been extensively evaluated in the
scientific literature as a reliable tool to diagnose pregnancy in many two-toed ungulates (R. M. Wallace et
al., 2015). Commercial assays are available and can detect PAG concentrations in both maternal blood
and milk (Reese, Pereira, Edwards, Vasconcelos, & Pohler, 2018). Accuracy of detecting circulating
PAGs is reported to range from 93-96% (Pohler et al., 2016). However, spurious results can occur
occasionally. For example, pregnant cows with a viable embryo, with evidence of beating heart of rectal
ultrasonography, have resulted with no detectable circulating PAGs (Pohler et al., 2015). It is unknown
whether this situation results from a fetus not producing PAGs that can enter and accumulate in maternal
5

circulation; or if the immunoreactive assay is not specific to the circulating PAGs subset. Circulating
PAG concentrations are highest prior to parturition and remain elevated post-partum due to a relatively
long half-life of up to 8-10 days (R. M. Wallace et al., 2015). Pregnant sheep demonstrate a temporal;
biphasic production of PAGs with an initial peak at gestation day 60 followed by a sharp decline by 90
days then a steady increase culminating with parturition (Roberts, May, & Veiga-Lopez, 2017). This
unique profile is speculated to be caused by a shifting in PAG production by the trophoblast and possibly
the insensitivity of the diagnostic assays to detect different subsets. It is interesting to note that the initial
decrease of PAGs in sheep corresponds when the trophoblast overtake the corpus luteum producing the
majority of progesterone for the remainder of pregnancy.
There are many potential functional roles of PAGs throughout pregnancy. Speculation of PAG
function is based on expression pattern and amount of proteolytic activity. Proteolytic PAGs produced at
the microvillar space could process growth factors or act to disrupt the connections between trophoblast
and uterine epithelium (Wooding, Roberts, & Green, 2005). Proteolytic activity is pH dependent; a
decline of pH is known to occur at the fetal-maternal microenvironment around parturition(Telugu &
Green, 2008). PAGs also may act as a bridging molecule assisting in adhesion at the maternal-fetal
interface microenvironment (R. M. Wallace et al., 2015). PAGs produced by binucleated giant trophoblast
can be sequestered in the maternal uterine stroma or enter maternal blood circulation. In cattle with
retained placenta, cotyledonary PAG expression is altered compared to control cows, supporting a local
regulatory role of PAGs in fetal membrane release (Hooshmandabbasi et al., 2018). Effects of PAGs
influence maternal physiology and immunity at the uterus and once distributed via blood circulation could
elicit systemic effects. In peri-parturient cattle, polymononuclear neutrophil activity is lowest at late
gestation, which corresponds with a marked increase of circulating PAGs (Dosogne et al., 1999).
However, correlation between occurrence of peri-parturient infectious disease and PAG concentrations in
cattle is speculative. Yet, direct immunomodulatory effects of PAGs are not clear. Administration of
PAGs can decrease hematopoietic cell proliferation and directly bind to uterine serpins thus augmenting
immune responses (Mathialagan & Hansen, 1996). The immune role of uterine serpins will be discussed
6

later in this chapter. Many PAGs display increased glycosylation, which can provide some protection to
the fetal semi-allograft by decreasing susceptibility to NK induced cell apoptosis (Perry et al., 2005).
Experimentally, PAGs have a luteotrophic role by increasing measurable prostaglandin E2 (PGE2), which
has direct luteotrophic and anti-luteolytic effects in ruminants thus increasing measurable progesterone
concentration (Weems, Kim, Humphreys, Tsuda, & Weems, 2003). Progesterone, itself has
immunomodulatory activity, which is discussed later in this review. Furthermore, PGE2 has a direct
immunosuppressive effect by inhibiting T-lymphocyte proliferation (P. J. Hansen & Liu, 1997). Thus,
PAGs can indirectly modulate immunity through the activation of other pathways that are experimentally
defined.
PAGs have been evaluated for their ability to serve as a marker for embryonic/fetal viability and
placental health. Circulating PAG concentrations are lower in cattle likely to undergo embryonic/fetal
loss. Beef cattle that maintain a pregnancy beyond 72 days of gestation have statistically higher
circulating PAG concentration at day 28 compared to cohorts that experienced embryonic/fetal loss by
day 72 of gestation (Pohler et al., 2013). All cows underwent transrectal ultrasonography, which
demonstrated a viable embryo at day 28 based on fetal heartbeat. Similarly, circulating PAGs were
decreased in beef cattle 41 days post insemination that had embryonic loss compared to cows that
maintained their pregnancy (Perry et al., 2005). However ability to detect pregnancy loss or embryonic
survival is assay antibody dependent (Gatea et al., 2018). Although these studies demonstrate an
association between low PAG concentrations and fetal loss, the opposite occurs with somatic cell nuclear
transfer (SCNT) derived embryos. Elevation in PAG levels is observed in recipient cows receiving
SCNT-derived embryos compared with control at days 35 and 50 of gestation followed by subsequent
fetal loss (Hashizume et al., 2002). This increase in circulating PAGs may reflect structural alteration of
the placenta allowing increased exposure of maternal epithelia to trophoblast products such as PAGs
(Pereira et al., 2013). PAGs have further been evaluated as a marker of placental health during
reproductive infections. Several studies have investigated shifting PAG concentration following
Neospora caninum infection in cattle. Lopez-Gatius et al. determined that PAG-1 concentrations
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decreased in aborting animals yet provided no indication of feto-placental health in chronically infected
pregnant cattle that did not abort (Lopez-Gatius, Almeria, et al., 2007). In another study, circulating PAG2 concentrations of < 4.5 ng/mL at day 120 of gestation served as an indicator of abortion risk in
chronically infected cattle (Garcia-Ispierto et al., 2013). Early PAG concentrations along with
seroconversion to Neospora demonstrated an odd ratio of seven for abortion by 5-7 months of gestation.
A negative correlation with other placental products such as plasma prolactin follows a similar
relationship in the face of Neospora induced abortion (Lopez-Gatius, Almeria, et al., 2007). These data
demonstrate that measurement of trophoblastic products such as PAG, can serve as a non-invasive marker
of placental health, possibly indicating the occurrence of fetal mortality.
3. Placental immunology during healthy pregnancy
Survival of the semi-allograft conceptus is required for successful pregnancy outcome (M. B.
Clark et al., 2007). The variety of placental types may have evolved to avoid immune rejection of the
fetus, which is antigenically different from the dam (Hemberger, 2013). The less invasive the
placentation, the less access of maternal immune cells will have to antigenically different fetal cells. The
underlying mechanisms for survival and non-rejection of the fetus is not fully understood, yet several
immunologic explanations have been proposed. For starters, the maternal immune system may be unable
to recognize fetal cells. Ruminant and human trophoblast have limited expression of major
histocompatibility complex (MHC) on its surface thus restricting the ability of immune cells to recognize
fetal antigens (Hill, Schlafer, Fisher, & Davies, 2002; E. Meeusen, Fox, Brandon, & Lee, 1993). Sheep
trophoblasts appear to be totally devoid of MHC I expression following gestational day 19 (GogolinEwens, Lee, Mercer, & Brandon, 1989). MHC molecules can act as antigens themselves, and in the case
of tissue graft or organ transplantation, T cells may recognize the tissue antigen and induce rejection.
Thus, the lack of MHC expression by trophoblasts prevent maternal recognition by CD8+ T cells,
ultimately preventing fetal rejection (Bainbridge, Ellis, & Sargent, 2000). Natural killer cells (NK) are
other such innate immune cells that utilize MHC molecules and other cellular receptors including killer
inhibitory receptors (KIRs) to recognize antigens. KIRs allow NK cells to recognize the absence of self,
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allowing them to kill cells that fail to produce MHC. This is a critically important mechanism for
elimination of virus-infected cells that down regulated MHC expression that would otherwise have been
missed by CD8+ T cells. NK are present in high number in the human and mouse decidua, and recently
NK have been described to have increasing numbers during early pregnancy in sheep (Entrican, 2002).
Human trophoblast appear to produce a limited amount of MHC to protect against NK induced apoptosis
(King, Allan, et al., 2000). With the known presence of NK in the gravid sheep uterus, it is unclear how
fetal trophoblasts that are devoid of MHC expression avoid NK-induced apoptosis; therefore, further
research is needed to elucidate these roles.
The population and phenotype of uterine leukocytes is altered with normal pregnancy. In sheep, T
cells in the uterine glandular epithelium greatly decrease in number while the number of macrophages
increases during pregnancy (Lee, Meeusen, Gogolin-Ewens, & Brandon, 1992). Tekin and Hansen
demonstrated that the accumulation of macrophages was due to both systemic and local signs by use of
unilateral uterine horn ligation studies in sheep (2004). The phenotype of uterine macrophages located in
the ruminant endometrium shifts to M2 (alternative) which function in tissue remodeling, healing, and
immunomodulation compared to its pro-inflammatory (M1) counter parts during pregnancy (Tekin &
Hansen, 2004). Concentrations of uterine ɣ/𝛿 T cell increase in ruminant placenta during mid and late
pregnancy (Lee et al., 1992; E. N. Meeusen, Bischof, & Lee, 2001). CD8+ ɣ/𝛿 T cell populations are
concentrated in the intercaruncular glandular and luminal epithelium where there is no chorionic
attachment, limiting exposure of fetal cells to this subset of maternal immune cells (Majewski, Tekin, &
Hansen, 2001). T cells expressing a ɣ/𝛿 receptor have less antigen specificity compared to their α/β
counterparts (i.e. CD4+ and CD8+ T cells). Yet, CD8+ ɣ/𝛿 T cell presence at the interplacentome tissue
suggests they control for excessive trophoblast invasion preventing danger to the dam yet minimizing
potentially detrimental immune responses to the placenta (Fox, Lee, Brandon, & Meeusen, 1998). CD4+
T cells are restricted to stromal epithelium of normal pregnancy (Cobb & Watson, 1995). B cells are low
numbers in the uterus during diestrus and concentrate in the deep stroma surrounding blood vessels
(Pereira et al., 2013). IgG is the primary immunoglobulin produced while IgA is in higher concentrations
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in the vagina (Cobb & Watson, 1995; Leung, Derecka, Mann, Flint, & Wathes, 2000; Mestecky,
Moldoveanu, & Russell, 2005). Lack of B cell populations and corresponding antibodies is confirmed by
population finding of less than 30% of multiparous cattle having anti-fetal antibodies in circulation
following parturition. These findings describe minimal maternal leukocytes at the caruncular regions
while number of leukocytes increase with the progression of pregnancy in the intercaruncular
endometrium ready to recognize and processing foreign antigens of pathogenic invaders (Leung et al.,
2000). Mechanisms inducing maternal T cell tolerance to fetal cells have been described in other species.
Human and mouse trophoblast expression indoleamine 2,3 dioxygenase is required for successful
pregnancy with the concluded action of inhibiting CD8+ T cell function (Kudo & Boyd, 2000). Further,
FAS ligand is expressed by human trophoblast and can induce apoptosis in activated T cells that bear
Fas/CD95 receptor thus preventing trafficking of activated lymphocytes to the maternal-fetal interface
(Mor, Gutierrez, Eliza, Kahyaoglu, & Arici, 1998). This supports the hypothesis of an anti-inflammatory
giving way to a pro-inflammatory uterine environment during late term pregnancy described in many
species (Gardner & Moffett, 2003).
Cytokines and chemokines, produced by both maternal and fetal cells, are important mechanisms
of communication at their interface. During diestrus and early pregnancy, the endometrial immune
environment favors a Th2 profile (Mineo, Oliveira, Gutierrez, & Silva, 2010). Uterine CD8+ ɣ/𝛿 T cells
in pregnant sheep express mRNA for anti-inflammatory cytokines including TGF- β, and IL-10 (Fox et
al., 1998). Human chorionic villus trophoblasts express mRNA for both pro- and anti-inflammatory
proteins including TNF- α, IFN- α, IL-1 β, TGF- β, and IL-10 (Bennett et al., 1999; King, Hiby, et al.,
2000). The concentration of pro-inflammatory cytokines has been confirmed at the fetal-maternal
interface in mice using ELISAs (Jokhi, King, & Loke, 1994; Jokhi, King, Sharkey, Smith, & Loke, 1994).
However, the effect of a pro-inflammatory milieu leading to fetal rejection is counteracted by high
concentrations of IL-10 (Chaouat et al., 1995). Interferons, including IFNT produced by the trophoblast,
have inherent antiviral properties and alter the function of target cells (Bazer, Song, & Thatcher, 2012).
The function of IFNT produced by the trophoblast as a signal for maternal recognition may have evolved
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from other type I IFNs (Ealy & Wooldridge, 2017). At the maternal fetal interface prostaglandins have a
pro-inflammatory feature (P. J. Hansen & Liu, 1997). In vitro, ovine INFT reduced PGF2α concentrations
confirming its antiluteolytic properties and inferring an immunosuppression role during early pregnancy
(Chen et al., 2006; Parent, Villeneuve, Alexenko, Ealy, & Fortier, 2003). Similar to other members of the
IFN group, IFNT has been demonstrated to have antiviral activity and inhibitory effect on lymphocytes
(Chen et al., 2006). Thus, there appears to be a cytokine balance between pro- and anti-inflammatory
stimuli that is critical for successful pregnancy.
Another immune alteration during successful pregnancy is maternal immunosuppression.
Pregnancy hormones have been demonstrated to have immunomodulatory effects. Beyond the functions
of establishment and maintenance of pregnancy, progesterone has many immunologic effects at the
maternal-fetal interface. Progesterone exerts this role by influencing immune cell functionality. In humans
and mice, progesterone plays a role in inhibiting mature dendritic cells (DCs), favoring immature DCs
populations at the decidua. DCs are important APCs that can activate T-cells hence having major
influences on the immune response within tissue. Immature DCs exhibit an anti-inflammatory phenotype
defined by increased expression of IL-10 (anti-inflammatory cytokine) and induction of T-regulatory
cells. Additionally, progesterone can bind to activated T-cells directly, producing progesterone induced
blocking factor (PIBF) via signaling through the JAK/STAT pathway (Kozma, Halasz, Polgar, et al.,
2006). PIBF influences T cell and NK response, favoring a Th2 response, leading to down regulation of a
pro-inflammatory response (Kozma, Halasz, Palkovics, & Szekeres-Bartho, 2006; Szekeres-Bartho,
Faust, Varga, Szereday, & Kelemen, 1996). Urine concentrations of have been positively correlated with
successful pregnancy outcomes in women (Polgar et al., 2003). Progesterone itself can induce TH2-type
cytokine production of IL-4 and IL-10 (Monterroso & Hansen, 1993; Piccinni et al., 1995). Both IL-4 and
IL-10 decrease TH1 and macrophage activity thus preventing allograft type rejection of the fetus. The
shift of Th1 to Th2 response seems clinically important for maintenance of pregnancy, where woman who
suffer from reoccurring abortion or miscarriage was associated with defective IL-4 production (Piccinni et
al., 1995). Progesterone appears to have another indirect role for immunosuppression beyond affecting
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uterine immune cells. Majewski demonstrated the infusion of progesterone induced secretory molecule
release from the uterine endometrium, thought to increase maternal-fetal communication and prevent fetal
rejection (Majewski et al., 2001). This action was independent of lymphocyte inhibition (Padua, Tekin,
Spencer, & Hansen, 2005). It was further elucidated that progesterone induces the release of bioactive
molecules known as serpins from uterine epithelium that have an immunoregulatory role (Liu & Hansen,
1993; Monterroso & Hansen, 1993). Uterine serpins in sheep have been found to inhibit lymphocyte
proliferation and NK cell function (Liu & Hansen, 1993; Peltier, Liu, & Hansen, 2000). Uterine milk
protein (UTMP) a type of serpin is a progesterone glycoprotein produced by endometrium epithelium (P.
J. Hansen & Liu, 1997). During pregnancy, UTMP is the predominant fluid in sheep uterine secretions
(Moffatt, Bazer, Hansen, Chun, & Roberts, 1987). In-vitro, UTMP inhibits activated T cells yet in-vivo
studies are lacking (P. J. Hansen et al., 1987). These roles elude to a progesterone-dependent
immunomodulation of the dam during pregnancy (Arck, Hansen, Mulac Jericevic, Piccinni, & SzekeresBartho, 2007).
Another immune theory during pregnancy follows the theory that during normal, healthy
pregnancy the semi-allogenic fetus does not propose any threat to the dam (Matzinger, 1998). This lack of
danger signals is thought to eliminate the necessity of the maternal immune response to reject the fetus
(Entrican, 2002). Danger associated molecular patterns (DAMPs) are signals produced by cells suffering
from damage and non-apoptotic death. DAMPs can bind to cellular receptors such as TLRs that can
initiate gene expression of inflammatory products. This and many other theories speak to a multimechanistic immune approach for successful pregnancy.
4. Placental immunology during infectious disease
The most notable infectious reproductive diseases in livestock are those that are vertically
transmitted causing placental pathology and abortion (Entrican, Buxton, & Longbottom, 2001).
Pathogens including Neospora caninum, Chlamydophila abortus, and bovine viral diarrhea virus
(BVDV), will create unapparent maternal disease while manifesting severe reproductive clinical disease
including abortion. This may be due to the inherently, anti-inflammatory immune milieu at the maternal12

fetal interface creating an environment incapable of control or prevention of an infectious pathogen.
Conversely, abortion maybe a consequence of the pro-inflammatory shift to Th1 environment resulting in
immunopathology. It is important to note that mechanisms of abortion will different between pathogens.
For the purpose of this review, select pathogens representing diverse organisms and the mechanism of
abortion induction in ruminants will be discussed. Beyond specific pathogens, maternal physiologic
stress, with and without disease can induce fatal consequences for the developing fetus. Stress associated
with disease processes that activate the hypothalamic-pituitary axis inhibits the female reproductive
system thus down regulating progesterone production, inducing spontaneous abortion (Magiakou,
Mastorakos, Webster, & Chrousos, 1997). Cortisol release associated with inflammation can impair PAG
production and activity (Dosogne et al., 1999). An abortion outcome may be directly associated with
insufficient progesterone to maintain a pregnancy or the loss of progesterone-dependent immune
modulation. Consequently, maternal stress alone is of significant consequence to the developing fetus.
Trophoblasts express toll-like receptors (TLRs), allowing binding of specific pathogen associated
molecular patterns (PAMPs) leading to immune-related gene expression (Takeda & Akira, 2005). The
most expression of TLRs and thus strongest ability to recognize pathogens are found on trophoblast
located at the chorionic villi which interdigitates with maternal endothelium (Takeda & Akira, 2005).
Following activation, trophoblasts can produce cytokines associated with a pro-inflammatory immune
response (Mineo et al., 2010). Maternal uterine endothelium also recognizes PAMPs and can produce a
variety of chemokines, cytokines, and antimicrobial compounds in response. Defensins are one such
compound that can produced and highly conserved across species. Beta-defensins have been identified at
the mucosal surface of the gastrointestinal, respiratory, and reproductive system of sheep (Meyerholz et
al., 2004). Expression of these proteins is associated with bacterial and viral pathogens at these surfaces
(Grubor, Ramirez-Romero, Gallup, Bailey, & Ackermann, 2004; Meyerholz et al., 2004). In humans, the
endometrium produces large concentration of defensins following pathogen recognition. Further, these
proteins can acts as chemokines for immature DC and memory T cells (Yang et al., 1999). Maternal
immune cells within uterine tissues will also recognize pathogens. Leukocyte TLR activation is needed to
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initiate host defenses against pathogens. Once antigens are processed APCs and presented, CD4+
lymphocytes secrete cytokines like IL-2 and B cells produce specific antibodies as plasma cells (Cobb &
Watson, 1995). Yet, with maturation of APCs and NK along with pro-inflammatory cytokine production
will affect the feto-placental units access to blood flow, nutrient exchange, and exposure to hostile,
activated immune cells.
C. abortus, a gram-negative bacterium, is the causative agent of ovine enzootic abortion. In nonpregnant sheep, infection is unapparent. Infection during pregnancy results in a delayed abortion, 6-7
weeks following the organism reaching the fetal compartment (Entrican et al., 2001). C. abortus has a
strong placental tropism in many species. In sheep, the organism replicates in the chorionic villus
trophoblasts. As discussed above, the binucleate trophoblasts at the placentome create and release
significant products required for successful pregnancy. Infected trophoblast have insufficient production
of necessary products like progesterone. A crucial consequence of decreasing progesterone leads to
increasing estrogen concentration, resembling a temporal hormone pattern associated induction of
parturition. Increasing estrogen concentrations along with decreasing progesterone increases oxytocin
activity and myometrium contraction, initiating labor. This reduction of progesterone can also result in the
loss of the immunomodulatory benefits of this pregnancy hormone at the maternal-fetal interface.
Resultant immunopathology of the placenta also plays a role with infectious abortion with C. abortus.
Innate immune cells like neutrophils, not usually found in the gravid uterus, infiltrate the caruncular
regions (Buendia et al., 1998). Neutrophils are beneficial in phagocytizing and killing the bacterium, yet
the pro-inflammatory environment defined by the presence of cytokines such as TNF- α can have
detrimental effects on pregnancy. A link between IL-8 and neutrophil recruitment has been examined
between placental endothelium damage and consequently pregnancy termination from lack of blood
supply to the fetal compartment (D. E. Clark, Salvig, Smith, & Charnock-Jones, 1998). Consequently, the
combined costs of C. abortus placental infection leads to fetal rejection and expulsion.
Neospora caninum, a protozoon, is the most common cause of infectious abortion in cattle,
worldwide (Reichel, Alejandra Ayanegui-Alcerreca, Gondim, & Ellis, 2013). Neospora associated
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disease and pregnancy outcomes depends on maternal immunity and stage of gestation at time of
infection. Infection during the first trimester results in severe congenital defects in the offspring, yet risk
of transmission to the fetus increases with gestational progression (Innes, 2007). Similar mechanisms of
placental pathogenesis and resultant abortion are shared between N. caninum and Toxoplasma gondii, a
cause of protozoan abortion in small ruminants (Menzies, 2011). Reproductive pathogenesis and fetal loss
is associated with placental insufficiency (Lopez-Perez, Collantes-Fernandez, Aguado-Martinez,
Rodriguez-Bertos, & Ortega-Mora, 2008). In cattle, placental invasion by tachzoites results in a proinflammatory shift of Th1 based cell population resulting in a cytokine storm. Although the Th1
influenced immune response is needed to control the infection, an excess of INF-ɣ, IL-4, and IL-12 is
detrimental toward the fetus (Arranz-Solis et al., 2016). Following mid-gestation inoculation of pregnant
ewes, N. caninum induced CD8+ T cell infiltrates and upregulation of INF- ɣ, IL-4, TNF- α, and IL-10
thus depicting a mixed Th1-Th2 response. In cattle, uterine serpin expression was negatively correlated
with IL-4 and INF- ɣ cytokine concentrations at the maternal fetal interface following N. caninum
infection (Serrano-Perez et al., 2018). This microenvironment contributes to the observed necrotizing
inflammation associated with placental and fetal infection (Lopez-Perez et al., 2008). Consequently, the
large inflammatory response leading to hemodynamic changes to local tissue can further lead to fetal
hypoxia. Not surprisingly, the fetal trophoblast expression also changes following parasitic invasion of
placental tissues. Bovine trophoblasts have an altered transcriptome demonstrating impaired cholesterol
biosynthesis and extracellular matric disorganization with upregulated TLR-2 expression and cytokine
production (Horcajo et al., 2017). Also, decreased concentration of circulating prolactin and PAG-2 have
been associated with abortion at 5-7 months following N. caninum infection (Garcia-Ispierto et al., 2013).
All of these factors lead to fetal morbidity and mortality following N. caninum placental infection.
Placental pathogenesis associated with viral infections can induce fetal loss via several
mechanisms. In the mouse, viral infection induces an upregulation of INF- ɣ, which in turn can increase
trophoblast MHC expression (Vassiliadis & Athanassakis, 1994). This aberrant expression of MHC may
contribute to viral pathogen associated abortion, as increased maternal INF- ɣ expression is associated
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with spontaneous abortion (Vassiliadis & Athanassakis, 1994). Many viruses interrupt the type I IFN
pathway following cellular infection allowing evasion of the immune cells (Baigent et al., 2002). Type I
IFN family proteins consist of IFNT, IFN- α, IFN- β. The benefits and roles of type I IFNs in pregnancy
successes have already been discussed in this review.
5. BVDV fetal infections
BVDV is a pathogen of cattle worldwide. The virus is differentiated by genotype, one and 2, now
defined as pesitvirus A and B, and biotype, cytopathic (cp) and non-cytopathic (ncp). Both genotypes
present with similar clinical manifestation in livestock. The biotype, immune status of the dam, and the
stage of gestation of infection determines the outcome of reproductive BVDV induced disease.
Subclinical disease in the dam can result in failure of conception, embryonic death, abortion, fetal
persistent infection, congenital defects, and congenital-transient infections. Maternal peak viremia occurs
around 7 days post inoculation (dpi) with elimination of the virus by 14 dpi. Both phenotypes can cross
the placental to cause fetal infection, yet only ncp BVDV viruses are capable of producing persistently
infected (PI) offspring. In PI neonates, the viral antigen is recognized as self, limiting the type I IFN
response needed for viral control. These animals continually shed the virus, maintaining the pathogen
within a population. Disease associated with reproductive BVDV infection in sheep parallels what is
observed in cattle.
During pregnancy, acutely infected dams transmit BVDV vertically to their fetus. Although the
dam has effectively cleared the virus, she demonstrates a compromised immune response. Viral RNA is a
recognized PAMP triggering the innate immune response characterized by IFN response. An antiviral
state is set into motion with IFN pathway activation, continuing with an adaptive immune response.
Following infection spreading to the fetal compartment, dams demonstrate sustained down regulation of
chemokine receptor 4 (CXCR4) and TCR pathways (T. R. Hansen et al., 2010; Shoemaker et al., 2009).
CXCR4 is expressed on platelets, immune, and neuronal cells and participate in many biological
processes most notably immune cell trafficking, and embryonic development in vasculo- and
neurogenesis (Nagasawa, Tachibana, & Kishimoto, 1998). Down regulation of TCR pathways interferes
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with cellular defense. BVDV antigen is not found again in maternal circulation after viral elimination
even when carrying an infected fetus (T. R. Hansen et al., 2010). However, pregnant heifers carrying a PI
fetus will have low, positive virus neutralization (VN) antibody titers 15 dpi which continually increase
through 115 dpi. These data support the continual exposure of the maternal immune response to fetally
derived virus yet local immunity prevents repeating maternal viremia. This gestational titer profile is not
observed in heifers carrying congenital, transiently infected (CI) fetuses (T. R. Hansen et al., 2010).
Smironova et al. described differential gene expression of circulating leukocytes of heifers carrying these
two different populations of BVDV infected fetuses. Both groups had increased expression of interferon
stimulated genes (ISG) including ISG15, 44, and 28; oligoadenylate synthetase 1 (OAS-1) and myxovirus
resistance factor 2 (MX2) (Smirnova et al., 2008). Upregulated expression of these mRNA are prominent
in innate immune responses to viral pathogen. An upregulated type I IFN response has also been
described in developing calves during gestation following BVDV infection (Shoemaker et al., 2009).
Type I IFN can act as a growth-suppressive with long-term increased expression thus contributing to
overall fetal morbidity associated with viral infection (Iwase et al., 1997).
Following reproductive infection BVDV antigen is localized to uterine luminal and glandular
epithelium, placentomes, and intercotyledonary fetal membranes (Fredriksen, Press, Sandvik, Odegaard,
& Loken, 1999). BVDV antigen can also be detected in uterine macrophages and T cells (Baszler,
Evermann, Kaylor, Byington, & Dilbeck, 1995; Fredriksen et al., 1999; Lopez, Osorio, Kelling, & Donis,
1993). In ewes inoculated with ncp BVDV-2 isolate at 55-60 days of gestation, viral replication at the
placentome from seven to 21 dpi was observed, with severe fibrinous ulcerative placentitis developing
over time (Scherer et al., 2001). Binucleate trophoblasts demonstrated a larger portion of BVDV antigen
compared to mononuclear cells (Swasdipan, Bielefeldt-Ohmann, Phillips, Kirkland, & McGowan, 2001).
Consequently, trophoblasts suffering from BVDV infection have altered creation of need products for
successful pregnancy including INFT and progesterone. As a type I IFN, INFT may have inherent antiviral properties yet the role of IFNT in BVDV infected placenta has not been elucidated (Swasdipan et al.,
2001). In ovaries from PI cattle, luteal cells are positive for BVDV antigen and resulting in altered
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hormone production (Booth, Stevens, Collins, & Brownlie, 1995; Fredriksen et al., 1999). Luteal cell
production of progesterone is required for maintenance of pregnancy in early gestational sheep.
Disruption of this production can lead to pregnancy failure. We can infer that the immunomodulatory
effects of progesterone leading to a pro-inflammatory shift at the maternal-fetal interface can also
contribute to viral pathogenesis. These described immune modifications following transplacental BVDV
infection leads to intra-uterine growth restriction (IUGR) associated with placental insufficiency.
Evidence of IUGR has been demonstrated in several studies evaluating birth weight and bone structure of
PI versus TI and control calves (T. R. Hansen et al., 2010; Nuss et al., 2005; Webb, McGilvray,
Smirnova, Hansen, & Norrdin, 2013). As with other infectious pathogens, placental and uterine pathology
caused by alteration of multiple pathways results in detrimental side effects to the fetus.
6. Exosomes – biogenesis and function
Extracellular vesicles (EV) are produced by almost all mammalian cells. Currently EVs are
classified based on size, content, and mechanism of production. Exosomes are one type of EV and are
distinct in their biogenesis. Exosomes are formed with in intraluminal vesicles inside multivesicular
bodies (MVBs). These MVBs are created from budding from the endoplasmic reticulum. Cargo
installation into exosomes requires several steps involving endosomal proteins. Eventually, MVB fuse
with the plasma membrane effectively dumping the exosomes via exocytosis into the extracellular space.
Exosomes can be identified based on the presence surface marker proteins, size, and density. Once in the
extracellular environment, exosomes can interact with cells locally in a paracrine manner or distributed in
circulation to act in an endocrine mode. Recipient cells can uptake exosomes via catharadin-induced
endocytosis, phagocytosis, or pinocytosis (Tian, Wang, Wang, Zhu, & Xiao, 2010). EVs such as
exosomes play a role in cell-to-cell communication. Exosomes have been shown to effect a wide arrange
of regulatory functions including immunity (Raposo & Stoorvogel, 2013). EV contain protein, nucleic
acid, and lipid contents that can be shared with recipient cells thus imparting effects on cellular processes.
EV can be isolated from a variety of biological fluids including serum, whole blood, milk and amniotic
fluid in livestock and humans (G. Burns et al., 2014). Studies in humans have investigated EV content as
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a non-invasive biomarker during disease conditions including complicated pregnancies (Hausler et al.,
2010).
EV are believed to be a mode of maternal-fetal communication during pregnancy via transfer of
EV contents between the conceptus and endometrium. Further, it is hypothesized that embryonic
implantation is depended on uterine exosomes, critical for pregnancy recognition in ewes (Brooks, Burns,
& Spencer, 2015; Ng et al., 2013; Ruiz-Gonzalez et al., 2015). Labeled maternal EV from the luminal and
glandular epithelium traffic and interact directly with the trophoblast of the conceptus (G. Burns et al.,
2014). It is proposed that lipid content of EV help with embryonic cell growth and other cargo may effect
function, proliferation, adhesion and attachment. In vitro, EV stimulate trophoblast proliferation and
IFNT production (Ruiz-Gonzalez et al., 2015). In sheep, the total number of endometrial derived EV in
uterine lumen are positively correlated with progesterone concentration therefore helping to establish an
embryotrophic environment (G. W. Burns et al., 2018). This concept in confirmed in women, who have
50 fold greater exosomes in circulation during pregnancy (Salomon et al., 2016). Exosome concentration
also increases considerable with gestational age when fetal-maternal contact surface area and blood flow
also increase (Sarker et al., 2014).
Several roles of EV have been proposed during healthy pregnancy. Exosome exchange between
the endometrium and cytotrophoblasts is associated with structural remodeling, allowing increased uterine
blood blow during gestation (Desrochers, Antonyak, & Cerione, 2016). EV demonstrate an
immunomodulatory role during pregnancy. Vesicles are thought to suppress maternal immunity by
inhibiting T cell and NK activation, which are prominent in uterine endometrium during pregnancy
(Mincheva-Nilsson & Baranov, 2014). Placental exosomes modulate cytokine release attenuating NK and
CD8+ and ɣ/𝛿 T cells in a dose dependent manner (Hedlund et al., 2009). Placental EV can content and
transfer immunosuppressive messengers like syncytin-1, which decreases pro-inflammatory cytokines,
TNF-α, and IFN-ɣ concentrations (Than et al., 2008). It is important to remember that all activity of EVs
is associated with their content and bioactivity.
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Exosomes are released under both normal and pathologic conditions. Secretion of EV is altered in
pathologic pregnancies conditions such as in pre-eclampsia (Adam et al., 2017). Furthermore, oxygen
tensions and glucose concentrations, both indicators of placental metabolism and blood flow, influence
EV release (Rice et al., 2015). Circulating exosome concentration is greater in pregnant woman compared
to controls, yet pre-eclampic woman have 40% greater exosomes than women with healthy pregnancies
(Goswami et al., 2006). This eludes to a role in maternal-fetal communication during times of placental
disease. Utilization of EV as a form of cell-cell communication has been well described in human
pregnancy, yet warrants further research in livestock.
Exosomal content can be altered with viral infection. When infected with Dengue Virus,
exosomes contain a larger amount of type I IFN based proteins needed for cellular antiviral responses
(Zhu et al., 2015). Many RNA viruses, including HIV and PRRSV, utilize exosomes from virally infected
cells to spread infectious viral RNA and proteins to susceptible cells (Narayanan et al., 2013; L. Wang et
al., 2018). With the help of exosomes, HIV+ exosomes target CD4+ T cell, inducing activation, and
making them susceptible to HIV replication (Arenaccio et al., 2014). Hepatitis A virus mimics exosome
formation by encapsulating fully infectious viral particles into vesicles derived from endosomal
membranes (White, Llinas-Brunet, & Bos, 2006). Within the membrane, hiding viral antigens from
antibodies capable of neutralization. The use of exosomes by important livestock viruses during
reproductive pathology has not been explored.
7. MicroRNAs during pregnancy & disease
MircoRNAs (miRNAs) are less than 25 nucleotide base pairs in length and pay a role in gene
expression (Reid, Kirschner, & van Zandwijk, 2011). These non-coding RNA products regulate gene
expression by repression of translation or inducing transcript decay ultimately leading to intracellular
silencing (Ouyang, Mouillet, Coyne, & Sadovsky, 2014). Pre-miRNA genes are transcribed and
processed in the nucleus, then exported to the cytoplasm as an immature, stem-loop miRNA (Guo & Lu,
2010). In the cytoplasm, they are further processed by endonucleases to form mature, short sequences
(Hutvagner et al., 2001). There are over 1500 miRNAs identified in humans (Ouyang et al., 2014).
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Protein or EV bound MiRNA can be isolated from blood, urine, and milk in many species including
ruminants (Pohler et al., 2015; Reid et al., 2011). Packaging of miRNA within the lipid bilayer of EV
prevent breakdown by endogenous RNA-ases, perhaps increasing their effectiveness by increasing the
likelihood of reaching recipient cells (Reid et al., 2011). Human based studies have determined
differential abundance of specific miRNAs associated with neoplasia, sepsis, and pregnancy status (Chen
et al., 2006; Hausler et al., 2010; J. Wang et al., 2010). Thus, miRNAs are thought to have important
regulatory function in many tissues including the reproductive system. In immunity, miRNA profiles are
associated with decreasing cortisol production and DAMPs signaling associated with inflammation
eluding to an anti-inflammatory role (Fleshner & Crane, 2017). Certain miRNAs are upregulated by proinflammatory pathway activation of NFκ-b in macrophages, aiding in a robust immune response
following LPS stimulation (Taganov, Boldin, Chang, & Baltimore, 2006). Furthermore, miRNAs have
been shown to increase granulocyte and NK activity (Mehta and Baltimore, 2016).
Roles of miRNAs within the reproductive system are well studied in humans and more recently,
livestock. MiRNAs have been demonstrated in ovarian function including follicular and ganulosa cell
development (Andreas et al., 2016; Gebremedhn et al., 2015). During diestrus, progesterone appears to
play a role in miRNA expression. In sheep, progesterone administration altered miRNA cargo of EV
found in the uterine lumen (G. W. Burns et al., 2018). Progesterone-up-regulated miRNAs have been
explored in other species as well (Cochrane et al., 2012). Burns et al. were able to characterize unique
miRNAs within in EV associated with progesterone treatment in sheep (G. W. Burns et al., 2018).
Pregnancy specific miRNAs have been extensively investigated in pregnant human and now more
research is focused on this population of miRNAs in horses, cattle, and sheep (G. Burns et al., 2014;
Klohonatz et al., 2016; Pohler et al., 2017). Burns et al. characterized EVs and miRNA profile in pregnant
sheep in the uterine lumen and hypothesized their role in maternal-fetal communication (Brooks et al.,
2015). Several studies have identified circulating miRNAs in cattle as potential biomarkers for early
pregnancy detection (Ioannidis & Donadeu, 2016; Pohler et al., 2017). In humans a placenta-cluster of
miRNAs, chromosome 19 miRNA cluster (C19MC) has been distinguished as trophoblast specific that
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are eliminated following (Ouyang et al., 2014). Furthermore, this group of miRNAs has been
characterized within exosomes. Expression of C19MC in trophoblast appears to be dependent on location
and behavior, with invasive villous trophoblasts expressing more of this miRNA cluster (Xie, Han, Liu,
Han, & Liu, 2014; Y. F. Xie et al., 2014). Greater C19MC expression correlates with maternal uterine
stroma interaction, increasing the likelihood that miRNAs will gain access to maternal circulation.
Chromosome 14 miRNA cluster (C14MC) are also associated with pregnancy in humans, however,
unlike C19MC, their concentration decreases as pregnancy progresses (Ouyang et al., 2014). Recently,
several miRNAs were identified in serum of pregnant cattle at 24 days of gestation (Gebremedhn et al.,
2018). These miRNAs identified shared homologous structure to C14MC miRNAs, and thought to be
pregnancy specific. Further research is needed to determine trophoblast specific miRNAs and quantify
their presence in maternal circulation in livestock.
Once in circulation, miRNAs have the ability to affect maternal physiology through gene
silencing. The full understanding of miRNAs biological actions during pregnancy remain to be
elucidated, however, their presence has been associated with a variety of pregnancy related
pathophysiological conditions. In humans, circulating miRNAs are biomarker candidates for pregnancy
related diseases including ectopic pregnancy, intrauterine growth restriction, and eclampsia (P. Li et al.,
2013; Miura et al., 2015; Mouillet et al., 2010). Differential expression and abundance of miRNA has
been investigated as a marker for pregnancy outcome in livestock. In cattle, differential miRNA are
defined as markers of embryonic viability, with evidence supporting differential expression prior to
embryonic mortality (Pohler et al., 2017). In SNCT pregnancy, overall low abundance of exosomal
miRNAs at 21 days of gestation was associated with unsuccessful pregnancy outcome (De Bem et al.,
2017). Twenty-seven miRNAs were more abundant in SCNT pregnancy that reached term. Using gene
ontology, the miRNAs were strongly associated with cell proliferation, angiogenesis, and embryonic
development (De Bem et al., 2017). Based on these recent studies and the body of literature in human
pregnancy, miRNAs have a potential to serve as a biomarker to assess pregnancy status and placental
health yet standardization of methodology is needed.
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MiRNAs activity in the face of viral infection has been investigated. Trophoblastic C19MC
confer resistance to viral infection by promoting autophagy in cell culture yet concentration of miRNA
was not influenced by viral infection in in-vivo modeling (Dumont et al., 2017)). This resistance effect
was not observed with bacterial or protozoan challenges (Bayer et al., 2018). However, this finding has
not been reproduced in vivo. In cell culture, bta-miR-2411 decreased BVDV replication in infected cells
(Shi et al., 2018). MiRNAs have also been used as a mechanism for viruses to avoid host immunity. A
portion of the human herpes virus genome encodes for miRNAs that can be transferred to other host cells
(Pegtel, van de Garde, & Middeldorp, 2011). Once inside a recipient cell, viral origin miRNA act as host
miRNAs and silence gene expression, thus down regulating IFN responses needed to control viral
infection. With the current understanding of the role of exosomes and miRNAs in intercellular
communication, it is not surprising that viruses would have a means to exploit this host mechanism.
8. EV Proteomics of pregnancy
Proteomic content in EV during pregnancy is a new field of research and thus not well described
in published literature; however, more has been described in humans. A proteome analysis of all EV
during the first trimester in humans revealed a protein profile involved with vesicle transport and
inflammation, including annexin V and complement proteins (Tong et al., 2016). Jia et al performed the
only EV proteome profile performed in abnormal pregnancy. They profiled the exosomal proteome in
umbilical cord blood comparing healthy and pre-eclampic pregnancy (Jia et al., 2015). Twenty-nine
proteins were differential abundant based on disease status, demonstrating an altered expression profile of
exosomal proteins in pre-eclampsia pregnancy possibly contributing to the pathogenesis of this condition.
In bovine uterine exosomes during early pregnancy, 172 differentially abundant proteins were identified
including IFNT (Kusama et al., 2018). The exosomal proteome shifted with a 1.5 fold change with
conceptus attachment. Upregulated proteins were associated with regulation of adhesion molecule
expression and apoptosis. Kusama et al. concluded that these exosome and their cargo are required for
conceptus attachment (Kusama et al., 2018). Studies have evaluated change in endometrial proteome of
pregnant sheep prior to attachment of the conceptus. Using a unilateral pregnant sheep model,
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Arianmanesh et al. determined expression of endometrial proteins in early gestation (Arianmanesh,
Fowler, & Al-Gubory, 2016). Several proteins associated with metabolism and cellular adhesion,
including apolipoptroin A and heat shock proteins were differential abundant. With what is known of the
production and interaction of endometrial EV and corresponding nucleic acid content with the conceptus,
investigation of EV proteome content is a worthy area of exploration.
9. Conclusions
Communication between the maternal and fetal tissues is critical for allow successful pregnancy.
This is supported by the exchange of proteins, nucleic acids, biologically active lipids at this interface at
the time of attachment and progression through a healthy gestation. The alteration of these compounds
are notable during times of pregnancy complications associated with infectious placental pathogenesis.
Further exploration of these maternal and fetal products is critical to gain a full understanding of the
milieu environment during healthy and disease pregnancy. After identification of markers associated with
feto-placental health and pathology, mechanisms of biologic activity can be elucidating using in-vitro and
in-vivo methodology. Furthermore, biomarkers associated with pathologic conditions may be identified
and used to assess placental health during gestation.
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Chapter 2
Alteration of pregnancy associated glycoprotein concentration in pregnant sheep infected
with bovine viral diarrhea virus
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Abstract
Pregnancy-associated glycoproteins (PAGs) are proteins produced in large quantities from the
placenta of even-toed ungulates. PAGs are used as a marker of pregnancy status and exhibit temporal
expression patterns. The purpose of this study was to evaluate alterations of PAG1 concentrations in
pregnant sheep following exposure to Bovine Viral Diarrhea Virus. Fifteen pregnant, yearling sheep were
randomly assigned to two treatments groups. At 65 days of gestation, ewes underwent intranasal
inoculation with 107 TCID50/mL of non-cytopathic BVDV New York-1 clinical isolate or equivalent
volume of media for sham inoculation. Venous blood was collected at gestational day 60 and 85. At
gestational day 85, uterine venous blood, amniotic fluid, and fetal tissue were collected via laparotomy.
Successful fetal transmission of BVDV was confirmed with RT-PCR of fetal tissue. Blood PAG1
concentrations were determined using a commercially available ELISA. PAG1 concentrations were
compared between treatment group and site of collection using ANOVA analysis. PAG1 concentrations
in jugular and uterine vein blood differed between treatment groups, with mean concentrations
significantly lower (P =0.04 and 0.01, respectively) in BVDV inoculated dams compared to controls at
gestational day 80. No significant concentration difference was found in amniotic fluid PAG1
concentrations (P > 0.05). In conclusion, infection with BVDV decreases PAG1 concentration in
maternal circulation in pregnant sheep compared to healthy controls. Maternal PAG concentrations may
be a viable biomarker to determine placental health following reproductive viral infections.

26

Keywords
Pregnancy-associated glycoproteins
Sheep
Bovine Viral Diarrhea Virus
Placenta
1. Introduction
Bovine viral diarrhea virus (BVDV) is an economically important pathogen of livestock,
worldwide. The reproductive outcome of BVDV fetal infection is largely dependent on the immune status
of the dam, stage of gestation at the time of infection, biotype and virulence of the infecting virus (Kelling
& Topliff, 2013). Data collected from a recent meta-analysis demonstrated that BVDV infection of naive
dams during gestation results in fetal infection in greater than 95% of exposures (Newcomer, Walz,
Givens, & Wilson, 2015). Potential reproductive sequelae include reduced conception, embryonic death,
abortion, development of persistent infection, congenital malformations, and transient fetal infection
(McGowan, Kirkland, Rodwell, Kerr, & Carroll, 1993). Many ungulate species are susceptible to BVDV
infection (Passler, Ditchkoff, & Walz, 2016; Passler et al., 2014). Reproductive effects of pregnant ewes
exposed to BVDV demonstrate similar disease progression and outcome as cattle, therefore insights into
maternal-fetal health in the face of BVDV infection can be directly correlated (Scherer et al., 2001).
Pregnancy associated glycoproteins (PAG) are produced by the ruminant trophoblast and
accumulate at the microvillar junction of the placenta (R. M. Wallace et al., 2015; Wooding et al., 2005).
The measurement of circulating PAGs in maternal blood and milk is commonly used to determine
pregnancy status in ruminants (Commun et al., 2016; Reese et al., 2018). Although the function of PAGs
are not fully understood, circulating concentrations have been evaluated as a biomarker of placental
health (R. M. Wallace et al., 2015). Decreases in circulating PAG concentrations have been associated
with embryonic loss and Neospora caninium induced abortion (Gatea et al., 2018; Pohler et al., 2013; J.
M. Wallace, Aitken, Cheyne, & Humblot, 1997). Additionally, PAG concentrations are associated with
abnormal placental development in dams carrying somatic cell nuclear transfer fetuses (Constant et al.,
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2011). Variations in PAG concentrations have never been evaluated in regard to reproductive viral
infections.
The purpose of this study was to determine the effect of BVDV fetal infection at gestational age
85 on maternal systemic blood, uterine outflow blood, and amniotic fluid concentrations of PAG1. Our
hypothesis is that PAG1 concentrations in BVDV infected sheep would decrease in each compartment
compared to sham-inoculated, pregnant controls and the ensuing decline in concentration can be used as a
marker of fetal health.
2. Materials and Methods
2.1 Animals
All animal work was approved under the guidance of the University of Tennessee Institutional
Animal Care and Use committee (protocol 2479). Fifteen, yearling primiparous Kahtadin ewes were
acquired from local sources and enrolled in the study. The ewes underwent estrous synchronization as
described: an intravaginal insert containing 0.9 g progesterone (EAZI-BREED CIDR sheep insert, Zoetis
Inc., Parsippany, New Jersey) was placed then removed after seven days, 5 mg dinoprost tromethamine
(Lutalyse Injection, Zoetis Inc.) was intramuscularly administered at the time of removal. Ewes were
housed with a fertile ram for natural service. Pregnancy diagnosis and confirmation using transabdominal
ultrasound occurred at gestational day (GD) 30 and 60, respectively. At confirmation, 11 ewes exposed to
the ram had similar pregnancy lengths at GD 60 while the remaining 4 ewes carried younger fetuses and
were excluded from the study. After confirmation of pregnancy, sheep were then randomly allocated
between two treatment groups: BVDV (n = 6) or CTRL (n = 5). A larger number of experimental units
were allotted to the BVDV group to account for expected fetal loss following inoculation. At GD 65,
ewes received intranasal inoculation of non-cytopathic BVDV type 2 isolate NY- 1 (107 TCID50/mL) or
equivalent volume of media to serve as sham. Blood was collected at GD 65 and 80 via jugular
venipuncture. Whole blood was allowed to clot for 30 minutes then centrifuged at 3000 x g for 10
minutes, then the serum removed, aliquotted and stored at – 80 0 C until analysis. At GD 80, 15 days post
inoculation (dpi), sheep were placed under general anesthesia and hysterectomy performed. A 12 to 15
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cm long incision was made on midline, starting immediately cranial to the udder. The linea alba was
identified and incised to enter the abdomen. The uterine horns were carefully exteriorized and the uterine
vein ipsilateral to the gravid horn identified to collect 3 mL of blood via catheterization with a 21 g
butterfly catheter, afterward a fine needle aspiration of 3 mL of amniotic fluid was collected. En bloc
resection of the complete uterus containing all fetal tissue was obtained by creating window in the broad
ligaments to double ligate 1 cm apart the ovarian pedicle with #1 or #2 absorbable suture material (either
polydioxanone or polyglactin sutures) before transection. The uterine body was ligated at the cervix using
one encircling ligature and one transfixing ligature using #1 or #2 absorbable suture material before
section of the uterine body and en bloc resection of the complete uterus. The body wall was closed in 3
layers: peritoneum with the linea alba and subcutaneous tissues in simple continuous patterns using #1
absorbable suture material, and the skin in a Ford interlocking pattern using #1 non-absorbable braided
suture material (polyamide) as described by Noordsy (Noordsey, 1995). Fetal and maternal tissue where
placed on ice and processed within 30 minutes of removal. Representative tissues of each fetus and
placentomes were flash frozen in liquid nitrogen. All samples were then stored at -80oF until analysis.
2.2 PAG analysis
PAG concentrations were determined in serum originating from the jugular and uterine vein as
well as amniotic fluid using a commercially available pregnancy specific protein B (PSPB) enzymelinked immunoassay (ELISA) (BioPRYN, BioTracking LLC, Moscow, Idaho). PSPB is a placental
protein consisting of an unknown number of PAG variants (Roberts et al., 2017). For the purpose of this
paper, the authors will refer to PSPB as PAG1. The ELISA assay was performed following
manufacturer’s instructions. All samples were performed in duplicate including protein standard, nonpregnant sheep serum and late gestation pregnant sheep serum as negative and positive controls
respectively. Plates were read within 30 minutes of completion of the ELISA on a plate reader at 650 nm
and concentrations estimated based on derivation from a standard curve run in duplicate with each plate.
Standard best fit line was accepted with a fit R2 > 0.989. Mean intraassay CVs based on two quality
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control pools were less than 3 and 5%. The interassay CVs for the same quality control pools were 2 and
15%, respectively.
2.3 Progesterone measurement
Progesterone concentrations were determined on serum collected from the jugular vein at GD 85
using commercially available radioimmunoassay (ImmuneChem Progesterone kit, MP Biomedicals, LLC,
Orangeburg, NY). The assay was performed following manufacturer’s guidelines with an additional 15minute incubation period prior to centrifugation of the precipitated solution. Intra- and interassay
coefficients of variation were both <10%.
2.4 BVDV inoculum preparation
Viral isolate BVDV non-cytopathic genotype 1b (pestivirus A), strain NY-1 was propagated in
Madin-Darby bovine kidney cells in Eagle’s minimum essential medium (EMEM) containing 10% fetal
bovine serum, L-glutamine, and penicillin G and streptomycin. Infection was induced as described by
Walz et al. (Walz, Givens, Cochran, & Navarre, 2008). All sheep where inoculated intranasally at GD 60,
to mimic naturally occurring maternal exposure (Swasdipan et al., 2001). Briefly, sheep were physically
restrained, haltered and the head elevated and stabilized. Using a disposable intranasal cannula, sheep
received 107 median tissue culture infective dose (TCID50) of the NY-1 isolate in EMEM (2mL
aliquot/nostril).
2.5 BVDV Polymerase chain reaction
Real time polymerase chain reaction (RT-PCR) was performed as described by La Rocca and
Sandvik on fetal tissue collected at GD 80 (15 dpi) to identify the presence of BVDV NY-1 (La Rocca &
Sandvik, 2009). Briefly, tissue was homogenized and RNA was isolated from samples using QIAamp
viral RNA mini kit according to manufacturer’s instructions (Qiagen, Hilden Germany). The reverse and
forward PCR primers for this reaction were GYGTCGAACCAYTGACGACT and
CCATRCCCDTAGTAGGACTAGC, respectively. A TaqMan probe (TaqMan, Applied Biosystems,
Foster City, CA) (TGGATGGCYRAABCCCTGAGT) with dye label 6-FAM on the 5’ end and Black
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Hole Quencher (BHQ, Integrated DNA Technologies, Coralville IA) on the 3’ end. Cycle threshold (Ct)
values over 20 were considered positive for BVDV genetic material.
2.6 Immunohistochemistry
Placentome tissues were fixed by immersion in 10% formalin. Tissues were routinely processed
and, paraffin embedded. Staining for BVDV was carried out using standard immunohistochemical
procedures developed for use in formalin fixed tissues. Five micrometer thick tissue sections were cut on
charged slides. Immunohistochemistry for BVD antigen was performed using the Discovery Ultra
Automated Staining System (Roche, Ventana Medical Systems, Tucson, AZ). Briefly, following
automated deparaffinization and antigen retrieval for 8 minutes using protease 2 retrieval solution (Roche,
Ventana Medical Systems, Tucson, AZ) at 37 degrees, sections were incubated with a monoclonal antiBVD antibody that specifically targets the BVDV glycoprotein E (clone 15.C.5., Syracuse Bioanalytical,
East Syracuse, NY, USA) at a concentration of 1:400 for 1 hour. Labeling was detected using the
multimer based ultra-map anti-mouse detection system with a red chromogen (Roche, Ventana Medical
Systems, Tucson, AZ). Positive controls included ear notch tissues from BVD positive cows as confirmed
by PCR. For negative controls, the primary antibody was replaced with homologous nonimmune serum.
2.7 Statistical analysis
Normal distribution of data was determined using PROC UNIVARIATE. Statistical analysis was
conducted using a one-way ANOVA using PROC GLM to test for differences in jugular vein PAG
concentration at GD 65 and 80, taking into account time and time x treatment interactions. PROC GLM
was used to determine difference in progesterone, amniotic fluid and uterine vein PAG concentrations.
Pearson and ranked-Spearman correlations were determined using PROC CORR. Power of test to
determine observations required to find equivalence between two treatments was determined using
POWER with TWOSAMPLEMEANS and TEST=EQUIV_DIFF. Significant difference between the
groups was considered significant when P < 0.05. All results are represented as mean with standard error
of the mean. All analyses were carried out using SAS version 9.4 (SAS Institute Inc., Cary, NC).
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3. Results
3.1 Confirmation of BVDV fetal-infection using PCR and IHC
Successful maternal infection and passage of BVDV into the fetal compartment was determined
by RT-PCR. Fetal tissue collected from a single sheep assigned to the BVDV inoculated group was found
to be negative on RT-PCR and excluded from the study leaving 5 experimental units in each treatment
group used for final analysis. Fetal tissues from dams inoculated with virus (n = 5) were found to be
positive on BVDV RT-PCR (mean Ct = 23.29, standard error of the mean 4.44). All fetuses of control
sheep (n= 5) were confirmed negative for the virus on RT-PCR (Ct = 0).
Microscopic evaluation of placentomes with hematoxylin and eosin stained slides did not identify
any significant light microscopic differences between inoculated and control animals. In control animals,
low numbers of mononuclear cells, predominantly lymphocytes were present in all levels of the
endometrial stroma. In inoculated animals, the intercaruncular luminal endometrial epithelium had mildly
increased numbers of intraepithelial mononuclear cells; however, the increase was not statistically
significant. BVDV antigen was detected by IHC within the trophoblastic epithelium lining
chorioallantoic villi in all pregnant sheep inoculated with BVDV. Figure A-1 is a representative image
from a single pregnant sheep inoculated with BVDV.
3.2 Changes in progesterone and PAG concentrations in sheep infected with BVDV
Mean progesterone concentrations are depicted in figure A-2. Mean progesterone concentration at
GD 80 trended downward in BVDV infected sheep compared to CTRL (P = 0.08). No significant
correlation was observed between progesterone concentrations and jugular PAG concentrations at GD 80
(see figure A-3; R2 < 0.1, P = 0.13). Mean jugular PAG concentrations at GD 65 and GD 80 are depicted
in figure A-4. Mean jugular PAG1 concentrations did not differ between treatment groups at GD 65 (P =
0.08), but significantly diverged at GD 80, 15 dpi (P = 0.04). Serum jugular PAG1 concentration differed
over time regardless of treatment group (P = 0.04). Concentrations at GD 65 significantly affected mean
PAG1 concentration at GD 80 (P = 0.03). Mean amniotic PAG1 concentrations for BVDV (45.59 ±
25.88 ng/mL) and CTRL (59.91 ± 22.05 ng/mL) sheep were not significantly different (P = 0.86). Mean
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uterine vein PAG concentrations are depicted in figure A-5. Mean uterine vein PAG1 concentrations were
significantly affected by treatment (P = 0.01) and significantly correlated using Pearson’s correlation with
jugular PAG1 concentration at GD 80 (P < 0.01). Figure A-6 is a scatter plot displaying significant
correlation between mean jugular and uterine vein PAG concentrations (R2 = 0.8, P < 0.01).
4. Discussion
The results of this study demonstrate successful experimental BVDV infection of pregnant ewes
at GD 65 and extension of the infection to the fetus by GD 80. The effect of this infection was
demonstrated by BVDV nucleic material found in fetal tissues and histopathologic evidence of BVDV colocated with placental inflammation. In addition, BVDV infection resulted in a significant decrease in
PAG concentrations associated between inoculation at GD 65 and experimental termination of the
pregnancy at GD 80 in both maternal systemic circulation and uterine vein outflow. To the authors’
knowledge, this is the first description of the effects of viral pathogenesis on PAG concentrations and
their correlation with fetal health.
4.1 BVDV induces maternal-fetal pathology
BVDV passage into the fetal compartment was confirmed with positive RT-PCR results in viral
inoculated sheep. The successful inoculation method performed in this study mimics natural maternal
exposure and resulting fetal infection in susceptible animals (Swasdipan et al., 2001). BVDV noncytopathic genotype 1b (pestivirus A), strain NY-1 was used for the infectious inoculation in this study.
As a non-cytopathic biotype, this BVDV strain is capable of producing an array of reproductive sequelae
following inoculation, including the creation of persistently infected offspring (Kelling & Topliff, 2013).
Efficient creation of a persistently infected offspring requires passage into the fetal compartments and
continued maintenance of pregnancy by the dam. The placental pathology observed on histopathology
was minimal in infected dams compared to controls, yet the presence of BVDV antigen within the
trophoblast was confirmed using IHC. Future studies, utilizing a more virulent strain of BVDV may
create significant placental pathology, thus altering maternal and fetal PAG concentrations even more
dramatically. It is important to note that no abortion associated with BVDV inoculation was observed in
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this study. This is consistent with other studies inducing fetal disease in small ruminants with BVDV. In
does infected with BVDV at GD 65, abortion occurred 7-65 dpi in less than 50% of inoculated animals
(Desouky, Younis, Ahmed, & Hegazy, 2011).
4.2 Changes in P4 and PAG concentrations with maternal-fetal BVDV infection
Although mean serum progesterone concentrations trended lower (P = 0.08) in BVDV infected
ewes, no significant difference was determined between infected and control sheep in this study. BVDV
infection can result in both oophritis and fetal death with subsequent release of PGF2a from the
endometrium, therefore it is often not clear which process has the greatest effect on serum progesterone
(Fray, Mann, Clarke, & Charleston, 1999, 2000). Several cell types in the bovine ovary are permissive to
BVDV, including cumulus cells, ovarian stroma, and the oocyte throughout its development, but luteal
cells appear to be inconsistently affected (Brownlie, Booth, Stevens, & Collins, 1997; Fray, Prentice,
Clarke, & Charleston, 1998). In non-pregnant naïve heifers, the serum progesterone and luteal tissues
were unaffected by BVDV infection in naturally cycling heifers, however synchronized heifers
demonstrated reduced serum progesterone during the early diestral phase and premature luteolysis (Fray
et al., 1999; Fray, Mann, et al., 2000). Yet, any cause of embryonic loss is associated with decreased
serum progesterone concentrations as result of indirect luteolysis (Gabor et al., 2016). Desouky et al
described evidence of luteolysis and oophiritis as well as falling progesterone concentrations in pregnant
does from GD 72 – 135 following inoculation at GD 65 (Desouky et al., 2011). In this report, luteloysis
was also either induced by fetal mortality and subsequent release of PGF2a or direct pathology to the
luteal tissue as 4 of 9 does aborted from 7 – 65 days post-inoculation. Progesterone, produced by the
corpus luteum and eventually the placenta, is important for the establishment and maintenance of
pregnancy (Spencer & Bazer, 2002). Moreover, the ovine placenta is the primary source of progesterone
after 50 days of gestation (Senger, 2004). Histopathology in this study suggested minimal placentitis at 15
dpi (GD 80), inferring that progesterone production was most likely normal in infected ewes at that time,
but the termination of gestations makes it impossible to know if ongoing pathology would have impaired
progesterone production at a later time point.
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Egen et al. described a biphasic profile of PAG concentration in maternal circulation among 31
tested ewes, where PAG concentration initially peaked at 185 ng/ml at GD 63 then decreased below 100
ng/ml by GD 125 (Egen, Ealy, Landon, Roberts, & Green, 2009). A similar temporal decrease was
observed in the current study between GD 65 and 80 in both treatment groups. However, the decline
among the BVDV infected ewes statistically exceeded that of the control ewes suggesting that by GD 80
the infected ewes were experiencing trophoblastic injury. This observation is supported by a similar
decrease in progesterone concentration and histopathologic evidence of placental inflammation co-located
with BVDV antigen. At GD 65, prior to inoculation, there was no significant difference in PAG1
concentrations between treatment groups, supporting that the expected temporal decline was not the sole
reason for decreasing PAG1 concentrations by GD 80. Wallace et al. also described a pattern of
decreasing PAG concentration among pregnant ewes fed two rations during this gestational period and
noted a sharper decrease in circulating PAG concentration among ewes experiencing non-infectious
abortion than ewes carrying fetuses to term (J. M. Wallace et al., 1997). Likewise, other authors have
correlated decreased PAG concentrations with embryonic loss in cattle in association with ovulatory
follicle size, Neospora caninum infection, heat stress, high milk production, and other unidentified
etiologies of fetal death (Garcia-Ispierto et al., 2013; Lopez-Gatius, Garbayo, et al., 2007; Mur-Novales et
al., 2016; Perry et al., 2005; Pohler et al., 2013). In the present study, because all gestations were
experimentally terminated at GD 80, it is not clear if the affected ewes would have demonstrated a
continued drop in PAG concentration, ultimately indicative of ensuing abortion, or once the fetus and
placenta had cleared the infection, PAG concentrations would have rebounded.
Jugular venous PAG concentrations were strongly correlated with uterine vein PAG
concentrations. As expected, the mean uterine venous PAG concentration was higher compared to jugular
samples, indicative of dilution and or decay of PAGs upon entry into the periphery. The fate of
peripherally circulating PAGs is unknown. Bovine PAGs have a variable half-life depending on stage of
pregnancy and range from 21.9 hours to 10 days. Nor is it known if the half-life changes in relation to
maternal physiology or in times of fetal stress or death. In experimentally induced, late embryonic
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abortion, the estimated half-life of PAGs ranged 21.9 hours to 3.9 days (Pohler et al., 2013; Szenci et al.,
2003)while immediately prior to parturition half-life increased to 8-10 days (de Sousa et al., 2003). As a
secretory product of fetal trophoblasts, several functions have been proposed. Experimental evidence
supports immunomodulatory actions of PAGs allowing some protection to the semi-allograft placenta (R.
M. Wallace et al., 2015). Treatment with bovine PAG1 alters hematopoietic cell proliferation and
endometrial chemokine production (Austin, King, Vierk, Sasser, & Hansen, 1999; Hoeben et al., 1999).
Futhermore, uterine serpins, which directly inhibit lymphocyte proliferation, can be bound by PAGs in
vitro thus augmenting immunomodulatory actions (Peltier et al., 2000). PAGs that accumulate in the
maternal stroma would allow these trophoblastic products to directly influence maternal immune cells. In
addition to immunomodulatory roles, evidence suggests a luteotrophic action by PAGs. When treated
with PAGs, luteal cell increase production of prostaglandin E2, which is inherently luteotrophic and antiluteolytic in ruminants (Weems, Lammoglia, Vera-Avila, Randel, King, et al., 1998). It is interesting to
note that PGE2 is directly immunosuppressive, working by inhibiting lymphocyte proliferation, possibly
an indirect mechanism of PAG immunomodulary capabilities (Low & Hansen, 1988). Luteal cells
exposed to PAG resulted in increased measurable progesterone, thus supporting luteal tissue function and
thus maintenance of pregnancy (Weems, Lammoglia, Vera-Avila, Randel, Sasser, et al., 1998). The
effect of PAGs at the maternal-fetal interface and elsewhere in the maternal body requires further
investigation to define their function during pregnancy.
No significant differences in amniotic PAG1 concentrations were observed between infected and
non-infected control groups in the current study. This finding was in contrast that of Mur-Novales et al.
where PAG concentrations was elevated in the fetal compartments of dams infected with N. caninum
compared to non-infected controls (Mur-Novales et al., 2016). In that study, the authors proposed that the
increase in PAGs within fetal fluid was associated with placental damage and leakage into the fetal
compartment. In the current study, there was minimal placentitis most likely due to the non-cytopathic
nature and mild severity of the inoculating strain, both suggesting there was insufficient trophoblastic
injury to induce release of PAGs in significant concentrations into fetal fluid.
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5. Conclusions
This is the first study investigating alterations of maternal and fetal fluid PAG concentrations
following reproductive viral infection in ruminants. Data presented here demonstrate that BVDV
infection results in trophoblastic injury and a significant decrease in PAG concentrations in maternal
circulation and uterine vein blood. This indicates that circulating PAG concentrations may be used as a
marker of placental function in the face of reproductive infection with BVDV and adds to the growing
evidence that low PAG concentrations are correlated with placental dysfunction and fetal loss. Further
refinement into the temporal relationship of PAG production and function with a model of fetal infection
such as the viral model introduced here will yield future insights in evaluating these proteins as
biomarkers of the fetal-maternal unit.
6. Acknowledgements
This work was supported by the Center of Excellence Grant, provided by a joint contribution
from the State of Tennessee and the University of Tennessee. The authors would like to recognize Drs.
Aaron Baumann, Samantha Collins, Gessica Franco, and Rebecca Payton for assistance with data
collection and laboratory analysis.
7. Competing interests
The authors have no competing interests to disclose.

37

Chapter 3
Characterization of circulating exosomal microRNA transcriptome in pregnant and nonpregnant sheep infected with Bovine Viral Diarrhea Virus
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Abstract
The placenta is an active immunologic organ, modulating the maternal immune response during
pregnancy. Trophoblasts from the placenta release small membrane-bound vesicles called exosomes
which play an important role in intercellular communication by transferring nucleic acids and proteins
between cells. Exosomes have been found in the uterine luminal fluid within pregnant sheep, yet little is
known of about their role in intercellular communication during pregnancy in times of health and disease.
The hypothesis for this study states that exosomal cargo detected in maternal circulation will vary
depending on reproductive health status and viral exposure. The specific objectives were to 1)
characterize the profiles of circulating miRNAs in pregnant and non-pregnant sheep, and 2) determine the
difference in exosome miRNA profiles between non-infected and BVDV-infected pregnant and nonpregnant sheep. Twenty-three yearling ewes, found to be seronegative to BVDV on serum neutralizing
antibody serology, were enrolled in this study. Ewes were inoculated with BVDV NY-1 or non-infective
sham media. Fifteen days post inoculation, all animals underwent hysterectomy and peripheral blood
collection. Exosomes were isolated using ultracentrifugation and gradient density separation. Small RNA
were extracted and high throughput sequencing was performed. BVDV infection status was determined
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with BVDV RT-PCR, immunohistochemistry of fetal tissue, and virus neutralization. Statistical
differences between circulating concentrations of miRNAs were analyzed by analysis of variance for
repeated measures. Sixty million reads, identifying 1634 miRNAs were identified following highthroughput sequencing. Several unique miRNAs were isolated from BVDV exposed and/or pregnant
ewes. The identification of unique miRNAs supports the hypothesis that exosomes have a biological role
in fetal-maternal interactions that can be modulated by infection or pregnancy status.
Keywords
Micro RNA
Exosome
Sheep
Bovine Viral Diarrhea Virus
Placenta
1. Introduction
The placenta is the bridge between the maternal and fetal tissues. The fetal trophoblasts are
immunologically active, producing products that interact with maternal cells. Some products include
native molecules such as pregnancy associated glycoproteins (PAGs) and membrane protected
extracellular vesicles containing multiple forms of bioactive molecules (Pohler et al., 2017; Pohler et al.,
2016). Exosomes are small microvesicles, 30-20 nm in size, comprised of a lipid bilayer. The production
of exosomes form as a membrane extrusions of the endoplasmic reticulum known as a microvesiclar
bodies (MVB) which are ultimately released into the extracellular milieu via fusion with the interior of
the parent cell’s plasma membrane (Barile & Vassalli, 2017). Exosomes have received more attention
recently due to the diverse type of cells that produce them and their presence in bodily fluids (G. Burns et
al., 2014; Vlassov, Magdaleno, Setterquist, & Conrad, 2012). Exosomal cargo generally contains
proteins, nucleic acids, and bioactive lipids such as prostaglandins (Subra et al., 2010). The exosomal
content activity is determined by cell or tissue of origin and suggested to be involved with intercellular
communication thus effecting physiologic processes in recipient cells (Schorey & Bhatnagar, 2008;
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Vlassov et al., 2012). Once released, exosomes have paracrine effects on the local cell population or more
distant endocrine effects via peripheral circulation. The lipid bilayer surrounding exosomes serve as a
protective shield preventing non-specific degradation of the bioactive content of small non-coding RNA
and protein. Moreover, membrane bound proteins studding the lipid bilayer likely mediate interactions
with target cell receptors which may drive specific or more ubiquitous messaging. Using cantharadin
induced endocytosis, the exosomal membrane merges with the cell’s plasma membrane thereby exuding
its contents into the cytoplasm (Barile & Vassalli, 2017).
Exosomes have been found in venous circulation in humans, cattle, and sheep (Adam et al., 2017;
Gebremedhn et al., 2018; Ruiz-Gonzalez et al., 2015). Exosomal roles have been described in
reproductive setting including conceptus attachment in cattle, and placental complications in humans (Jin
& Menon, 2018; Kusama et al., 2018). In humans, exosomes released from trophoblasts have been
demonstrated to carry out an important role in intercellular communication by transferring nucleic acids
and proteins between fetal and maternal cells. Exosomes have been discovered in uterine luminal and
fetal fluid in sheep in times of healthy pregnancy (G. Burns et al., 2014). However, description of
circulating exosomes in livestock species during pregnancy associated infectious disease in absent.
MicroRNAs (miRNAs), less than 25 bp non-coding RNA, are one of the bioactive molecules
isolated from exosomes (Ouyang et al., 2014). These small RNA regulate gene expression by repressing
translation or inducing transcript decay, with an overall effect of silencing gene expression and largely
down regulating protein synthesis (Glazov et al., 2009). Pregnancy specific miRNAs have been in
pregnant women and recently investigated in miRNAs in horses, cattle, and sheep (G. Burns et al., 2014;
Klohonatz et al., 2016; Pohler et al., 2017). Attempts to infer the function of miRNAs associated with
trophoblastic exosomes has been through isolation and nucleotide sequencing which has yielded profiles
correlating with placental health and risk of fetal morbidity and mortality in humans (J. Y. Li, Yong,
Michael, & Gleadle, 2014; Mouillet, Ouyang, Bayer, Coyne, & Sadovsky, 2014; Ouyang et al., 2014). In
humans, circulating miRNAs are biomarker candidates for pregnancy related diseases including ectopic
pregnancy, intrauterine growth restriction, and eclampsia (P. Li et al., 2013; Miura et al., 2015; Mouillet
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et al., 2010). Bovine Viral Diarrhea Virus (BVDV) is an economically important virus of artiodactyls
worldwide (Passler & Walz, 2010). Susceptible animals infected with BVDV can suffer from a variety of
clinical manifestations including immunosuppression, diarrhea, and an array of reproductive disease. The
reproductive consequences seen in livestock are dependent on the stage of estrous or gestation the animals
is exposure (Newcomer et al., 2015). Fetal infections, when coinciding with specific developmental
timeframes, in cattle and sheep suffer from embryonic mortality, persistent fetal infection, congenital
developmental defects, and abortion (Walz et al., 2018). Previous studies have profiled the maternal
cytokine production and circulating mRNA transcriptome signature at differing stages of in-utero BVDV
infection from uterine vein blood revealing a prominent interferon response typical of viral infections (T.
R. Hansen et al., 2010; Smirnova et al., 2014).
In the face of viral infections, circulating exosome content and miRNAs are altered. RNA viruses,
including human-immunodeficiency virus and porcine respiratory reproductive syndrome virus, utilize
host cell exome production to aid in spread of viral proteins or infectious RNA to susceptible cell
(Narayanan et al., 2013; L. Wang et al., 2018). Chromosome 19 miRNA cluster, considered the
trophoblast specific miRNA in humans, confer viral resistance to non-placental cell in vitro (Dumont et
al., 2017). Recently, bovine miRNA 2411 was found to decreased BVDV replication in cell culture (Shi
et al., 2018)
MiRNA profiles have not been characterized during times of pathogen-associated placental
pathology in livestock. Describing this exosomal content may help characterize reproductive viral
pathogenesis and aid in potential biomarkers associated with placental pathology. The purpose of this
study was to identify and describe the small RNA transcriptome from exosomes found in circulation in
sheep. Furthermore, this study characterizes the differential miRNA expression found in relation to
pregnancy status and BVDV exposure in sheep.

2. Materials and Methods
2.1 Animals
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All animal work was approved under the guidance of the University of Tennessee Institutional
Animal Care and Use committee (protocol 2479). Twenty-three, yearling primiparous Kahtadin ewes
were acquired from local sources and enrolled in the study. Fifteen ewes underwent estrous
synchronization as described: an intravaginal insert containing 0.9 g progesterone (EAZI-BREED CIDR
sheep insert, Zoetis Inc., Parsippany, New Jersey) was placed then removed after seven days, 5 mg
dinoprost tromethamine (Lutalyse Injection, Zoetis Inc.) was intramuscularly administered at the time of
removal. Ewes were then housed with a fertile ram for natural service. Pregnancy diagnosis and
confirmation using transabdominal ultrasound occurred at gestational day (GD) 30 and 65, respectively.
At confirmation, 11 ewes exposed to the ram had similar pregnancy lengths at GD 65 while the remaining
4 ewes carried younger fetuses and were excluded from the study. After confirmation of pregnancy,
sheep were then randomly allocated between two treatment groups: PREGNANT-BVDV (n = 6) or
PREGNANT-CTRL (n = 5). A larger number of experimental units were allotted to the BVDV group to
account for expected fetal loss following inoculation. The remaining 8 ewes not exposed to the ram were
randomly allocated between two additional treatment groups: NON PREGNANT-BVDV (n =4) or NON
PRENANT-CTRL (n= 4). All Ewes received intranasal inoculation of non-cytopathic BVDV type 1
isolate NY- 1 (107 TCID50/mL) or equivalent volume of media to serve as sham at GD 65 based on
pregnancy confirmation. All non-pregnant ewes received intranasal viral inoculation or sham on the same
day as pregnant ewes. Blood was collected at GD 80 or 15 days post inoculation (dpi) via jugular
venipuncture. Whole blood was allowed to clot for 30 minutes then centrifuged at 3000 x g for 10
minutes, then the serum removed, aliquotted and stored at – 80 0 C until analysis. At 15 dpi, all sheep
were placed under general anesthesia and hysterectomy performed. A 12 to 15 cm long incision was made
on midline, starting immediately cranial to the udder. The linea alba was identified and incised to enter
the abdomen. The uterine horns were carefully exteriorized. En bloc resection of the complete uterus,
both gravid and non gravid were obtained by creating window in the broad ligaments to double ligate 1
cm apart the ovarian pedicle with #1 or #2 absorbable suture material (either polydioxanone or
polyglactin sutures) before transection. The uterine body was ligated at the cervix using one encircling
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ligature and one transfixing ligature using #1 or #2 absorbable suture material before section of the
uterine body and en bloc resection of the complete uterus. The body wall was closed in 3 layers:
peritoneum with the linea alba and subcutaneous tissues in simple continuous patterns using #1
absorbable suture material, and the skin in a Ford interlocking pattern using #1 non-absorbable braided
suture material (polyamide) as described by Noordsy (Noordsy, 1976). Fetal and uterine tissue where
placed on ice and processed within 30 minutes of removal. Representative tissues of each fetus and
placentomes in pregnant sheep were flash frozen in liquid nitrogen. Representative tissues of caruncular
tissue in non-pregnant sheep were also handled as described. All samples were then stored at -80oF until
analysis.
2.2 BVDV inoculum preparation
Viral isolate BVDV non-cytopathic genotype 1b (pestivirus A), strain NY-1 was propagated in
Madin-Darby bovine kidney cells in Eagle’s minimum essential medium (EMEM) containing 10% fetal
bovine serum, L-glutamine, and penicillin G and streptomycin. In-vivo infection was induced as
described by Walz et al. (Walz et al., 2008). All sheep where inoculated intranasally at GD 65, to mimic
naturally occurring maternal exposure (Swasdipan et al., 2001). Briefly, sheep were physically restrained,
haltered and the head elevated and stabilized. Using a disposable intranasal cannula, sheep received 107
median tissue culture infective dose (TCID50) of the NY-1 isolate in EMEM (2mL aliquot/nostril). Sheep
in the control groups were handled similarly, but received a equivalent volume of media to serve as a
sham inoculation.
2.3 Virus neutralizing assay for BVDV
Virus neutralization (VN) was used to detect serum antibodies against BVDV-1 and BVDV-2.
Serum was collected for VN assay prior to inoculation and 30 dpi. The BVDV-1 cytopathic stain NADL
and BVDV cytopathic strain 125c was used for this assay. VN was performed as described by Walz et al.
(Passler et al., 2014). Serum titer <1:4 was described as negative. A rising titer (4x) in paired serum
samples collected 3 to 4 weeks apart constitutes a good basis for the diagnosis of acute BVDV infection
(Lanyon, Hill, Reichel, & Brownlie, 2014)
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2.3 BVDV Polymerase chain reaction
Real time polymerase chain reaction (RT-PCR) was performed as described by La Rocca and
Sandvik on fetal tissue collected at GD 80 (15 dpi) to identify the presence of BVDV NY-1 (La Rocca &
Sandvik, 2009). Briefly, tissue was homogenized and RNA was isolated from samples using QIAamp
viral RNA mini kit according to manufacturer’s instructions (Qiagen, Hilden Germany). The reverse and
forward PCR primers for this reaction were GYGTCGAACCAYTGACGACT and
CCATRCCCDTAGTAGGACTAGC, respectively. A TaqMan probe (TaqMan, Applied Biosystems,
Foster City, CA) (TGGATGGCYRAABCCCTGAGT) with dye label 6-FAM on the 5’ end and Black
Hole Quencher (BHQ, Integrated DNA Technologies, Coralville IA) on the 3’ end. Cycle threshold (Ct)
values over 20 were considered positive for BVDV genetic material.
2.4 Immunohistochemistry
Uterine and placental tissues were fixed by immersion in 10% formalin. Tissues were routinely
processed and, paraffin embedded. Staining for BVDV was carried out using standard
immunohistochemical procedures developed for use in formalin fixed tissues. Five micrometer thick
tissue sections were cut on charged slides. Immunohistochemistry for BVD antigen was performed using
the Discovery Ultra Automated Staining System (Roche, Ventana Medical Systems, Tucson, AZ).
Briefly, following automated deparaffinization and antigen retrieval for 8 mins using protease 2 retrieval
solution (Roche, Ventana Medical Systems, Tucson, AZ) at 37 degrees, sections were incubated with a
monoclonal anti-BVD antibody that specifically targets the BVDV glycoprotein E (clone 15.C.5.,
Syracuse Bioanalytical, East Syracuse, NY, USA) at a concentration of 1:400 for 1 hour. Labeling was
detected using the multimer based ultra-map anti-mouse detection system with a red chromogen (Roche,
Ventana Medical Systems, Tucson, AZ). Positive controls included ear notch tissues from BVD positive
cows as confirmed by PCR. For negative controls, the primary antibody was replaced with homologous
nonimmune serum.
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2.5 Progesterone measurement
Progesterone concentrations were determined on serum collected from the jugular vein at GD 80
or 15 dpi using commercially available radioimmunoassay (ImmuneChem Progesterone kit, MP
Biomedicals, LLC, Orangeburg, NY). The assay was performed following manufacturer’s guidelines with
an additional 15-minute incubation period prior to centrifugation of the precipitated solution. Intra- and
interassay coefficients of variation were both <10%.
2.6 Exosome isolation
Extracellular vesicles were isolated from 2 mL of serum 15 dpi using a combination of
centrifugation gradient isolation. Each sample was centrifuged for 15 minutes at 3000 x g and cleared
supernatant transferred to sterile tube. Exosome precipitation was performed using a commercial kit
according to manufacturer’s instructions (ExoQuick, System Biosciences, Palo Alto CA). Cleaned
exosome pellets were suspended in 250 uL of PBS; 20 uL was saved for western blot analysis while the
remainder was used for miRNA extraction described below.
2.6.1 Western blot
Western blots were performed as described by Pohler et al (Pohler et al., 2017). Exosomes were
identified for immunopositivity to surface markers Cluster of differentiation 81 (CD 81) and Heat-shockprotein 70 (HSP 70). Both of these markers well characterized as identifiers of exosomes(Vlassov et al.,
2012).
2.7 MiRNA extraction and validation
Total miRNA was extracted from each biological replicate by using the miRNeasy mini-isolation
kit (Qiagen, Germantown, MD). The quantity and quality of miRNAs were evaluated on a small RNA
Labchip kit (Agilent Technologies, Santa Clara CA) using an Agilent 2100 Bioanalyzer according to
manufacturer’s instructions.
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2.8 Illumina RNA library preparation and sequencing
Three experimental units per treatment group that were positive on serum exosome
immunoreactivity for CD81 and HSP70 collected at 15 dpi were submitted for deep sequencing. All
miRNA sequencing was performed on the Illumina Hi Seq2500 system at University of Kansas Medical
Center Genomics Core (Kansas City, KS). All methods below have been validated and published by
author Pohler (Pohler et al., 2017). The final volume of extracted small RNAs were converted to cDNA
with the reverse transcriptase SuperScript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA)
according to the manufacturer's instructions for oligo dT priming. Second-strand cDNA was then
synthesized by following a protocol provided by Illumina; the protocol uses the Klenow fragment of
DNA polymerase I (Illumina, San Diego, CA). The double-stranded samples were purified with a
QIAquick PCR spin column (Qiagen). Libraries were constructed following the manufacturer’s protocol
with reagents supplied in Illumina’s TruSeq miRNA stranded sample preparation kit. Briefly, the
polyadenylated miRNA was purified from total RNA and fragmented. Double-stranded cDNA will be
generated from fragmented RNA, and the index containing adapters ligated. The final construct of each
purified library was evaluated using the Fragment Analyzer instrument, quantified with the Qubit
fluorimeter using the quant-iT HS dsDNA reagent kit (Invitrogen), and diluted according to Illumina’s
standard sequencing protocol for sequencing on an Illumina HiSeq 2500 sequencer. Sequence runs were
presented as 100 bp paired-end reads.
2.9 Statistical analysis
Normal distribution of data was determined using PROC UNIVARIATE. Statistical analysis was
conducted using a one-way ANOVA using PROC GLM to test for differences in mean progesterone
concentrations. Power of test to determine observations required to find equivalence between two
treatments was determined using POWER with TWOSAMPLEMEANS and TEST=EQUIV_DIFF.
Significant difference between the groups was considered significant when P < 0.05. All results are
represented as mean with standard error of the mean. All analyses were carried out using SAS version 9.4
(SAS Institute Inc., Cary, NC).
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2.9.1 Bioinformatics
Read quality was verified using FastQC, a quality control program that determines base content,
sequence quality, and adaptor content [1]. Next, the sequences were trimmed of their adaptor content
using Skewer, a program that takes user-defined transcripts and adapter sequences and trims them based
on the user’s parameters [2]. FastQC analysis indicated the presence of a single adaptor: the Illumina
small RNA 3’ adaptor; using this as the sole adapter sequence, Skewer was run using mostly default
parameters for single end trimming. Due to the smaller size of miRNAs, a minimum read length of 10
was chosen instead of Skewer’s default of 18. One of the 12 samples was split into two files due to the
total file size exceeding Illumina’s maximum file size; additionally, all samples were run on two lanes,
meaning that each sample had two files corresponding to each lane. These files were concatenated into a
single file for each sample after trimming, and FastQC was run again to confirm the removal of all
adapter content. Based on the methods of another small RNA study in Ovis aries, the sequences were
filtered to remove any reads with more than 30 base pairs [3].
The microRNA database, miRBase, contains the sequences for 106 known miRNAs annotated in
the O. aries genome [4-8]. To determine the percentage of reads that align with these known miRNAs,
UCSC’s BLAST-like alignment tool (BLAT) was used with special parameters to account for the smaller
size of small RNAs [9]. In particular, the step size, or spacing between tiles, was set to 1, minimum
sequence identity and score were set to 0, a high number of repetitions was used to avoid sequences being
marked as “overused,” and the “fine” option was selected. Accounting for the relative small number of
known miRNAs in O. aries, 5 additional species were used: fellow ruminants Bos Taurus (cow) and
Capra hircus (goat), and well-annotated mammalians Mus musculus, Rattus norvegicus, and Homo
sapiens. The design for this procedure was as follows; run BLAT to align sequences with one of the
miRBase hairpin libraries, filter out multi-mapping reads, and filter out any reads that match with a
miRNA. This process is repeated until reads matching any miRNA across the 6 miRNA libraries were
identified. After filtering, each sample had six files – one for each set of miRNAs – containing a list of
reads that aligned to known miRNAs from one of the six libraries. The filtering process ensured that no
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read was repeated between any of the six files, and any redundant miRNAs were collapsed into a single
instance. These files were concatenated into single files containing every known miRNA aligning to reads
from a sample, and a custom python script was used to count every instance of a miRNA in the combined
file and save these results to a new file.
Two factors were used in analysis to determine differential expression: the status of the uterus
(Non-Pregnant vs. Pregnant) and treatment with bovine viral diarrhea virus (CTRL vs. BVDV). The count
files for the 12 samples were exported to RStudio, and analyzed using the DESeq2 and EdgeR packages
[10-12]. DESeq2 was used to combine the individual counts files into a single data set, while EdgeR was
used to perform a quasi-likelihood F-test to identify genes with significant differential expression. This
analysis produced a list of miRNAs, based on EdgeR’s default adjusted p-value of 0.05 for QLF tests, that
were deemed differentially expressed. To visualize these results through heatmaps, the reads were
converted into log counts per million with an added count of 2 to avoid taking the log of zero.
Additionally, the top 50 genes – ranked on their adjusted p-value with a false discovery rate of 0.1– were
used to create Venn diagrams to identify genes unique to each treatment type. To be considered
biologically relevant, at least 2 out of 3 sheep sequenced per group were required to have abundant
miRNA expression defined by a count per million reads.
To identify if samples obtained from ewes infected with BVDV contained genetic data from the
virus, all remaining reads from the blat alignment and filtering step were aligned to the Ovis aries genome
(assembly Oar_v4.0,
ftp://ftp.ncbi.nlm.nih.gov/genomes/all/GCF/000/298/735/GCF_000298735.2_Oar_v4.0/GCF_000298735.
2_Oar_v4.0_genomic.fna.gz) using sensitive Bowtie2 alignment [14]. Bowtie2 produces a sequence
alignment/map (SAM) format file that marks the number of times a read aligns to the reference genome.
SAM Tools was used to create a separate binary SAM (BAM) file containing only reads that did not align
to the O. aries genome, and to generate a fasta file containing the sequences of these unaligned reads [15].
These reads were aligned to the completed BVDV genome (GenBank: KJ689448.1) with BLAT, using
the same parameters for short miRNA reads described above, to identify any overlap between the virus’
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genome and the unknown reads. In theory, the reads collected from infected ewes would contain more
reads that overlap with the BVDV genome than those collected from healthy ewes.
3. Results
3.1 Confirmation of BVDV infection using VN, PCR, and IHC
Prior to enrollment of the study, all sheep were negative (<1:4) for neutralizing antibodies to
BVDV, confirming immunologic naivety of the animals. All animals sham inoculated with sterile media
remained negative (<1:4) on VN throughout the study period. All animals enrolled in the BVDV group
who received intranasal viral inoculation had a positive titer on VN assay 30 days following viral
exposure. The mean titer for PREGNANT-BVDV was 1:32 (standard error of the mean (SEM) ± 6) and
Non-Pregnant-BVDV was 1:24 (SEM ± 6). Successful maternal infection and passage of BVDV into the
fetal compartment was determined by RT-PCR. Fetal tissues from dams inoculated with virus (n = 5)
were found to be positive on BVDV RT-PCR (mean Ct = 23.29 ± 4.44). All fetuses of PREGNANTCTRL sheep (n= 5) were negative for the virus on RT-PCR (Ct = 0).
Microscopic evaluation of placentomes with hematoxylin and eosin stained slides did not identify
any significant light microscopic differences between inoculated and control animals. In control animals,
low numbers of mononuclear cells, predominantly lymphocytes were present in all levels of the
endometrial stroma. In inoculated animals, the intercaruncular luminal endometrial epithelium had mildly
increased numbers of intraepithelial mononuclear cells. BVDV antigen was detected by IHC within the
trophoblastic epithelium lining chorioallantoic villi in all PREGNANT-BVDV sheep inoculated with
BVDV. Figure A-1 is a representative image from a single pregnant sheep inoculated with BVDV.
Histopathology of NON PREGNANT-BVDV sheep subjectively demonstrated mild cellular infiltration
of mononuclear cells with a mean of 17 cells compared to mean of 11 cells observed in NON
PREGNANT CTRL sheep. BVDV antigen was not visualized in uterine tissue of any sheep in the NON
PREGNANT-BVDV group.
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3.2 Progesterone concentrations between treatment groups
Mean progesterone concentrations measured 15 dpi for all treatment groups are depicted in figure
A-7. Mean concentrations for PREGNANT-CTRL sheep (2.77 ng/ml ± 0.86) was not significantly
different compared to PREGNANT-BVDV (1.65 ng/mL ± 0.52) and NON PREGNANT-CTRL (1.65
ng/mL ± 0.63) (P > 0.1). Mean progesterone concentrations for NON PREGNANT-BVDV was
significantly lower at 0.77 ng/mL (SEM ± 0.57) compared to PREGNANT-CTRL (P = 0.01) but did not
significantly differ compared to the remaining treatment groups (P = 0.1).
3.3 Evaluation of isolated exosomes and miRNA content
Exosomes were successfully isolated from circulating blood using chemical gradient
methodology. Confirmation of exosomes isolated from serum was performed using western blot, which
demonstrated immunostaining for exosome surface markers CD 81 and HSP 70. Figure A-8A displays a
representative image from a sheep assigned to the PREGNANT-CTRL group demonstrating a positive
western blot result for both CD 81 and HSP 70 along with positive and negative controls. All biologic
replicates for each treatment group were positive for these surface markers. Quantification of miRNAs
were performed for each biological replicate prior to sequencing. Mean miRNA concentration for each
treatment group are as follows: PREGNANT-CTRL 706.96 pg/ µL (SEM ± 177.87), PREGNANTBVDV 525.7 pg/µL (SEM ± 46.34), NON PREGNANT-CTRL 446.53 pg/µL (SEM ± 50.96), and NON
PREGNANT-BVDV 565.9 pg/µL (SEM ± 175.37). No significant difference was observed in miRNA
concentration isolated for each treatment group (P > 0.5). Figure A-8B portrays Agilent electropherogram
profiles of small RNAs extracted from circulating exosomes representative for each treatment group.
Clustering of small RNA species below 60 base pair in all samples is indicative of the presence of
miRNAs (Pohler et al. 2017).
3.4 Differential abundance of miRNAs between treatment groups
To determine the representative relative abundance of miRNAs between treatment groups,
miRNAs were sequenced from exosomes isolated from a subset of three sheep per treatment. Deep
sequencing of miRNA yielded 60 million reads in total with 1634 miRNAs identified. On average, 6.7
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million raw reads were obtained per sample with 2.8 million reads containing less than 30 base pairs. The
majority of reads mapped to bovine genome, yet miRNAs that were annotated to human, murine, ovine
and caprine genomes were also present. BVDV RNA was not identified in the sequenced products from
exosomes of any treatment group. Principal coordinate analysis of the total the 1634 miRNAs sequenced
produced overlapping populations of miRNA observed within each treatment group (figure A-9). Unique
miRNAs were detected in each treatment group and displayed in figure A-10. No miRNAs were
consistently present across all treatment groups. Ninety miRNAs were differentially expressed between
treatment groups. The 30 most abundant miRNAs identified that and were differentially expressed based
on viral exposure and pregnancy status are displayed in table A-1. From these 30 miRNAs, 14 were
differentially expressed based on exposure to BVDV and 16 miRNAs were differentially expressed by
pregnancy status.
4. Discussion
This study represents the first examination of exosomal miRNA content in pregnant and nonpregnant ruminants infected with BVDV. Exosomes were successful isolated from maternal circulation
using gradient methodology and confirmed with western blot. Following successful small RNA
extraction, sequencing, and transcriptomic analysis a total of 90 miRNAs were differentially expressed
between treatment groups defined by pregnancy status and exposure to BVDV. To the authors’
knowledge, this is the first study to characterize the miRNA content of exosomes produced during viral
induced reproductive pathogenesis.
4.1 BVDV induces maternal-fetal pathology
Confirmation that BVDV infection was achieved following inoculation used a combination of
RT-PCR, IHC, and VN assay results. Seroconversion with following BVDV exposure was observed 30
dpi. A rising titer (4x) in paired serum samples constitutes a good basis for the diagnosis of BVDV
(Lanyon et al., 2014). Observed histologic pathology was comprised of mild infiltration of white blood
cells to the caruncular and intercaruncular tissue. However, no major histologic lesions were observed in
either pregnant and non-pregnant sheep infected with BVDV. BVDV NY-1 is a relatively low virulence
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non-cytopathic strain of BVDV which accounts for the underwhelming amount of histologic
inflammation observed (Swasdipan et al., 2001). Perhaps the use of a more virulent strain of BVDV
would produce a more marked appearance of local tissue inflammation. BVDV antigen was identified
within the trophoblast in all pregnant sheep inoculated with the virus, confirming viral spread to the fetal
compartment by 15 dpi. Viral antigen was not identified at the caruncular tissue in non-pregnant sheep
infected with BVDV. BVDV is known to have a proclivity for reproductive tissue including the fetal
maternal interface and ovary (Fray, Paton, & Alenius, 2000; Swasdipan et al., 2001). In non-pregnant
sheep blood supply to the caruncular tissue and local tissue immunity is vastly different compared to
pregnant sheep (Swasdipan et al., 2001). This inherent difference is tissue activity may have limited the
presence of viral replication at endometrium observed 15 dpi. Progesterone in all sheep infected with
BVDV trended lower than non-infected counterparts with similar reproductive status, yet no significant
difference was observed. These data may have suffered from type II error, where a statistically
significant difference may have been observed with a larger sample size. BVDV infection can result in
both oophritis and fetal death with subsequent release of PGF2a from the endometrium, inferring that both
processes will have an effect on serum progesterone (Fray et al., 1999; Fray, Mann, et al., 2000).
4.2 Exosomal miRNAs are differentially expressed based on pregnancy and viral status
Exosomes are small microvesicles comprised of a lipid bilayer. In this study, exosomes were
isolated using a chemical gradient and were positive on western blot for exosomal surface markers CD81
and HSP70, which are well-described exosome markers (Conde-Vancells et al., 2008). Exosomal cargo
generally contains proteins, nucleic acids, and bioactive lipids such as prostaglandins (Subra et al., 2010).
MiRNAs impose their biological function by modulating gene expression by silencing mRNA leading to
suppression of translation and thus protein synthesis (Glazov et al., 2009). Profiles of miRNAs are being
investigated as markers of placental health during human pregnancy (Adam et al., 2017). This study
compared miRNA concentrations between sheep based on pregnancy status and exposure to BVDV. A
total of 90 miRNAs were differentially expressed between treatment groups using a FDR 0.1. Of those,
30 of the most abundant miRNAs were identified with expression difference based on pregnancy and
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BVDV exposure in 16 and 14 miRNAs, respectively. Several abundant miRNAs identified in this study
are novel for differential expression for both pregnancy status and viral associated infection. Spencer et
al. described oar-mir-19b in healthy pregnant sheep (G. W. Burns, Brooks, & Spencer, 2016). That
finding holds true in this study, as this miRNA is upregulated in only pregnant animals. Several miRNAs
whose differential expression found to be determined by pregnancy status did not hold true in this study
(Cleys et al., 2014; Ioannidis & Donadeu, 2016). Differences between other published results may stem
from our small number of experimental units per treatment group, thus lower the power and leading to a
type 2 error. Further, this study evaluated a different population of miRNAs by only sequencing
exosomal miRNAs compared to free miRNAs in circulation. The difference in methodology may account
for inconsistent results when trying to define miRNA profiles based on pregnancy status.
Several miRNAs that were upregulated in the BVDV exposed group were also described in the
literature as associated with other infectious conditions of livestock and humans. Bta-mir-2330 and btamir-10225b have been associated with BHV-1 infection in bovine derived cells in vitro (Glazov et al.,
2009). In small ruminants exposed to peste des petits ruminants, bta-mir-144 was found to be
upregulated in the clinically ill (Pandey et al., 2017). The miRNA has-mir-7-1 which was upregulated in
the BVDV exposed sheep was found to be associated with reproductive viral infections in humans. Other
differentially expressed miRNAs discovered in this study are were identified in fetal disease. For
example, hsa-mir-674 associated with fetal alcohol syndrome is upregulated in the BVDV-infected group
(Balaraman et al., 2014). Fetal alcohol syndrome results in dysregulation of nutrient and oxygen
exchange at the placental level (Balaraman et al., 2014; Balaraman, Tingling, Tsai, & Miranda, 2013). A
similar disequilibrium can be expected in placentitis associated with infectious condition.
Annotation of sequenced miRNA sequences was performed by aligning to several genomes
including ovine, bovine, caprine, human, and murine. The majority of the sequences were annotated to
the bovine miRNA genome, yet alignment to the other aforementioned species was observed in
differentially expressed miRNA. Homologous structures are described between bovine and both human
and murine miRNAs (Gebremedhn et al., 2018). However, it is unknown if the function of well-studied
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human or murine miRNA is the same in ruminant species. A pathway analysis using mirPATH v. 3 Diana
Tool was attempted yet the majority of bovine and ovine derived miRNA are relatively novel without
unknown mechanisms in biologic pathways (Vlachos et al., 2015). Prediction of miRNA targets in sheep
published in currently literature is indirect and based on conserved sequences across multiple species (G.
W. Burns et al., 2016).
Viruses including PRRSV and HIV utilize exosome-mediated transport of viral RNA allowing
cell-to-cell transmission (Arenaccio et al., 2014; L. Wang et al., 2018). Nucleic acids from BVDV
genome were not identified in the sequenced product isolated from exosomes. During the sequencing
process, researchers selected for nucleic acid segments of less than 100 bp, with the hope of identifying
miRNAs which are less than 50 bp. Narrowing the sequencing product of this size could have eliminated
the identification of viral nucleic acids, which could be closer to 250 bp in length (Ridpath & Bolin,
1995). Further research is needed to determine if BVDV may utilize the use of exosomes to mediate viral
transmission.
5. Conclusions
MiRNAs are known to play a role in a wide range of biological processes and thus their
expression may be disease specific making them excellent biomarkers. Many miRNAs identified in this
study are novel and not previously described in livestock with reproductive viral infection. The miRNAs
described in this study may provide a useful resource for future investigators to further characterize and
select candidate miRNAs for further analysis for biological relevance.
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Chapter 4
Characterization of the exosomal proteome in pregnant and non-pregnant sheep infected
with Bovine Viral Diarrhea Virus
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Abstract
The placenta is a transient organ, critical for growth and protection of the developing fetus.
Trophoblasts from the fetal placenta produce a variety of products including extracellular vesicles, such
as exosome. Exosomes have been found in pregnant sheep, yet little is known of about their role in
maternal-fetal communication during pregnancy during times of health and disease. The hypothesis of
this study states that exosomal proteome detected in maternal circulation will vary depending on
reproductive health status and viral exposure. The specific objectives were to 1) characterize the profiles
of circulating exosomal proteins in pregnant and non-pregnant sheep, and 2) determine the differential
abundance in proteome between non-infected and BVDV-infected pregnant and non-pregnant sheep.
Twenty-four yearling ewes, found to be negative to BVDV on serum neutralizing antibody serology, were
enrolled in this study. Ewes were inoculated with BVDV NY-1 or sham media. Fifteen days post
inoculation, all animals underwent hysterectomy and peripheral blood collection. Exosomes were isolated
using ultracentrifugation and gradient density separation. Mass spectroscopy proteomics were performed
and predicted protein forms identified using Proteome Discoverer Percolator. BVDV infection status was
determined with BVDV PCR of fetal tissue. Statistical differences between abundance of proteins were
analyzed of variance for repeated measures. With a confidence rate of 0.01, 539 proteins were identified
with differential relative abundance between viral exposure. This studies supports the idea that exosomes
containing select proteins are present in peripheral circulation likely have a biological role in fetalmaternal interactions important in times of both disease and health.
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1. Introduction
The placenta is an essential organ needed for growth and survival of the fetus. Maternal-fetal
cellular communication is critical to maintain a healthy pregnancy, and any dysfunction can result in fetal
morbidity or mortality (Adam et al., 2017). Exosomes (30-150 nm particles) are released from various
types of cells and can serve as communication channels between the dam and fetus (Jin & Menon, 2018).
In sheep production of exosomes is associated with progesterone production, with higher concentration of
vesicles isolated during pregnancy compared to non-pregnant sheep (G. W. Burns et al., 2018). This
concept in confirmed in women, who have 50 fold greater exosomes in circulation during pregnancy
(Salomon et al., 2016). Exosomal cargo comprised of proteins, lipids, and nucleic acids. Once released
from the parent cell, exosomes cause a function change in recipient cells dependent on their contents
(Barile & Vassalli, 2017). Studies in human pregnancy have linked exosomal content with placental
dysfunction, leading health complications for the fetus and dam(Jin & Menon, 2018). Examination of
exosomal content in livestock is limited, with a narrow scope evaluating only normal, uncomplicated
pregnancy (G. W. Burns et al., 2016). Proteomic evaluation of exosomes in pregnancy is relatively novel
with only a few publish reports in humans. Jia et al described differentially abundant proteins in cord
blood isolated from pre-eclampic woman compared to healthy controls (Jia et al., 2015). Characterization
of the protein contents of exosomes may help elucidate pathophysiologic mechanism during complicated
pregnancies.
Bovine viral diarrhea virus (BVDV) is a positive sense, RNA virus that affects all even-toed
ungulates (Passler & Walz, 2010). It is an economically important virus of livestock, worldwide, and can
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yield dramatic reproductive pathology resulting in failure to conceive, embryonic death, persistent fetal
infection, congenital fetal infection, and abortion (Newcomer et al., 2015). The virally induced pathology
at the maternal fetal interface tissue has been investigated using histopathology, protein arrays, and
mRNA transcription (T. R. Hansen et al., 2010; Smirnova et al., 2012; Smirnova et al., 2014). Other RNA
viruses, including HIV and PRSSV, have been demonstrated to alter exosome production and content in
infected cells (Narayanan et al., 2013; L. Wang et al., 2018). However, this viral mechanism has not been
evaluated in relation to BVDV infection. Examination of exosomal content may further elucidate viral
pathogenic mechanism during pregnancy in livestock.
Proteome profiling of circulating exosomes in pregnant animals is needed to better understand
placental immunology in times of health and disease. With the hypothesis that the exosomal proteome
would vary based on pregnancy and viral exposure status, we set out with the specific objectives to 1)
characterize the profiles of circulating exosomal proteins in pregnant and non-pregnant sheep, and 2)
determine the difference in exosome profiles between non-infected and BVDV-infected pregnant and
non-pregnant sheep.
2. Materials and Methods
2.1 Animals
All animal work was approved under the guidance of the University of Tennessee Institutional
Animal Care and Use committee (protocol 2479). Twenty-four, yearling primiparous Kahtadin ewes were
acquired from local sources and enrolled in the study. The ewes underwent estrous synchronization as
described: an intravaginal insert containing 0.9 g progesterone (EAZI-BREED CIDR sheep insert, Zoetis
Inc., Parsippany, New Jersey) was placed then removed after seven days, 5 mg dinoprost tromethamine
(Lutalyse Injection, Zoetis Inc.) was intramuscularly administered at the time of removal. Ewes were
housed with a fertile ram for natural service. Pregnancy diagnosis and confirmation using transabdominal
ultrasound occurred at gestational day (GD) 30 and 60, respectively. At confirmation, 11 ewes exposed to
the ram had similar pregnancy lengths at GD 65 while the remaining four ewes carried younger fetuses
and were excluded from the study. After confirmation of pregnancy, sheep were then randomly allocated
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between two treatment groups: BVDV (n = 6) or CTRL (n = 5). A larger number of experimental units
were allotted to the BVDV group to account for expected fetal loss following inoculation. At GD 65,
ewes received intranasal inoculation of non-cytopathic BVDV type 2 isolate NY- 1 (107 TCID50/mL) or
equivalent volume of media to serve as sham. Blood was collected at GD 80 via jugular venipuncture.
Whole blood was allowed to clot for 30 minutes then centrifuged at 3000 x g for 10 minutes, then the
serum removed, aliquotted and stored at – 80 0 F until analysis.
2.2 BVDV inoculum preparation
Viral isolate BVDV non-cytopathic genotype 1b (pestivirus A), strain NY-1 was propagated in
Madin-Darby bovine kidney cells in Eagle’s minimum essential medium (EMEM) containing 10% fetal
bovine serum, L-glutamine, and penicillin G and streptomycin. Infection was induced as described by
Walz et al. (Passler et al., 2007). All sheep where inoculated intranasally at GD 65, to mimic naturally
occurring maternal exposure (Swasdipan et al., 2001). Briefly, sheep were physically restrained, haltered
and the head elevated and stabilized. Using a disposable intranasal cannula, sheep received 107 median
tissue culture infective dose (TCID50) of the NY-1 isolate in EMEM (2mL aliquot/nostril).
2.3 BVDV Polymerase chain reaction
Real time polymerase chain reaction (RT-PCR) was performed as described by La Rocca and
Sandvik on fetal tissue collected at GD 80 (15 dpi) to identify the presence of BVDV NY-1 (La Rocca &
Sandvik, 2009). Briefly, tissue was homogenized and RNA was isolated from samples using QIAamp
viral RNA mini kit according to manufacturer’s instructions (Qiagen, Hilden Germany). The reverse and
forward PCR primers for this reaction were GYGTCGAACCAYTGACGACT and
CCATRCCCDTAGTAGGACTAGC, respectively. A TaqMan probe (TaqMan, Applied Biosystems,
Foster City, CA) (TGGATGGCYRAABCCCTGAGT) with dye label 6-FAM on the 5’ end and Black
Hole Quencher (BHQ, Integrated DNA Technologies, Coralville IA) on the 3’ end. Cycle threshold (Ct)
values over 20 were considered positive for BVDV genetic material.
2.4 Immunohistochemistry
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Placentome tissues were fixed by immersion in 10% formalin. Tissues were routinely processed
and, paraffin embedded. Staining for BVDV was carried out using standard immunohistochemical
procedures developed for use in formalin fixed tissues. Five micrometer thick tissue sections were cut on
charged slides. Immunohistochemistry for BVD antigen was performed using the Discovery Ultra
Automated Staining System (Roche, Ventana Medical Systems, Tucson, AZ). Briefly, following
automated deparaffinization and antigen retrieval for 8 minutes using protease 2 retrieval solution (Roche,
Ventana Medical Systems, Tucson, AZ) at 37 degrees, sections were incubated with a monoclonal antiBVD antibody that specifically targets the BVDV glycoprotein E (clone 15.C.5., Syracuse Bioanalytical,
East Syracuse, NY, USA) at a concentration of 1:400 for 1 hour. Labeling was detected using the
multimer based ultra-map anti-mouse detection system with a red chromogen (Roche, Ventana Medical
Systems, Tucson, AZ). Positive controls included ear notch tissues from BVD positive cows as confirmed
by PCR. For negative controls, the primary antibody was replaced with homologous nonimmune serum.
2.5 Exosome isolation
Extracellular vesicles were isolated from 2 mL of serum 15 dpi using a combination of
centrifugation gradient isolation. Each sample was centrifuged for 15 minutes at 3000 x g and cleared
supernatant transferred to sterile tube. Exosome precipitation was performed using a commercial kit
according to manufacturer’s instructions (ExoQuick, System Biosciences, Palo Alto CA). Cleaned
exosome pellets were suspended in 250 uL of PBS; 20 uL was saved for western blot analysis while the
remainder was used for proteomic analysis described below.
2.5.1 Western blot
Western blots were performed as described by Pohler et al (Pohler et al., 2017). Exosomes were
identified for immunopositivity to surface markers Cluster of differentiation 81 (CD 81) and Heat-shockprotein 70 (HSP 70). Both of these markers well characterized as identifiers of exosomes (CondeVancells et al., 2008).
2.6 Mass spectroscopy

61

Each multidimensional protein identification technology (MudPIT) fraction was subjected to inline Reverse Phase (RP) chromatography and tandem mass spectrometry to identify proteins in each
fraction. Briefly, each sample was loaded onto a C18 nano column using a Thermo Scientific RSLCnano
system. The flow rate was 200nl/min. Peptides were eluted from the column using a linear acetonitrile
gradient from 2 to 80% acetonitrile over 180 minutes followed by high and low organic washes into an
Orbitrap Fusion Lumos mass spectrometer (Thermo Scientific) via a nanospray source. The spray voltage
was set to 1.8kV and the ion transfer capillary was set at 275°C. A data-dependent Top 10 method was
used where a full MS scan from m/z 350-1600 was followed by MS/MS scans on the 10 most abundant
ions. Data dependent MS/MS data was collected using a collision induced dissociation(CID) energy of
35%, at a scan range of 400-1200m/z, and using higher energy collision dissociation (HCD) energy of
65% with a scan range of 100-500 m/z. A dynamic exclusion of 60s was set.
2.7 Statistical analysis
Raw data files were searched against the most recent database for Ovis Aries downloaded from
NCBInr using the MudPIT option in Proteome Discoverer 2.2 (Thermo Scientific) and the Sequest HT
search algorithm. For protein identification results, only peptides identified with high confidence were
used. Trypsin was the selected enzyme allowing for up to two missed cleavages per peptide.
Carbamidomethylation of cysteine, N-terminal TMT6-plex, and Lysine TMT6-plex were used as a static
modifications whereas oxidation of Methionine and TMT6-plex of Threonine were used as variable
modifications. For confidence, the Percolator algorithm was used for peptide-spectrum match (PSM)
validation in database searches. The False Discovery Rate (FDR) threshold calculated in Proteome
Discoverer Percolator (Thermo Fischer Scientific, Waltham, MA) when high confidence peptides was
used for protein identification is 0.01. The relative abundance of identified proteins in each sample was
determined by calculating the ratios in pairwise comparisons using SAS version 9.4 (SAS Institute Inc.,
Cary, NC). Graphical representation of proteome distribution via scatter plot and up and down regulated
biological processes were created using XLSTAT 2018 (Addinsoft, New York, NY)

62

3. Results
3.1 Confirmation of BVDV infection using VN, PCR, and IHC
Prior to enrollment of the study, all sheep were negative (<1:4) for neutralizing antibodies to
BVDV, confirming immunologic naivety of the animals. All animals undergoing sham inoculation with
media remained negative (<1:4) on VN 1 month following intranasal inoculation. All animals enrolled in
the BVDV group who received intranasal viral inoculation had a positive titer on VN assay 1 month
following viral exposure. The mean titer for PREGNANT-BVDV was 1:36 (standard error of the mean
(SEM) ± 6) and Non-Pregnant-BVDV was 1:24 (SEM ± 6). A rising titer (4x) in paired serum samples
constitutes a good basis for the diagnosis of BVDV (Lanyon et al. 2014). Successful maternal infection
and passage of BVDV into the fetal compartment was determined by RT-PCR. Fetal tissues from dams
inoculated with virus (n = 5) were found to be positive on BVDV RT-PCR (mean Ct = 23.29 ± 4.44). All
fetuses of PREGNANT-CTRL sheep (n= 5) were negative for the virus on RT-PCR (Ct = 0).
Microscopic evaluation of placentomes with hematoxylin and eosin stained slides did not identify
any significant microscopic differences between inoculated and control animals. In control animals, low
numbers of mononuclear cells, predominantly lymphocytes, were present in all levels of the endometrial
stroma. In inoculated animals, the intercaruncular luminal endometrial epithelium had mildly increased
numbers of intraepithelial mononuclear cells. BVDV antigen was detected by IHC within the
trophoblastic epithelium lining chorioallantoic villi in all PREGNANT-BVDV sheep inoculated with
BVDV. Figure A-1 is a representative image from a single pregnant sheep inoculated with BVDV.
Uterine tissue from NON PREGNANT-BVDV was not positive for BVDV antigen on IHC.
3.2 Evaluation of isolated exosomes
Exosomes were successfully isolated from circulating blood using chemical gradient
methodology. Confirmation of exosomes isolated from serum was performed using western blot, which
demonstrated immunostaining for exosome surface markers CD 81 and HSP 70. Figure A-11 displays a
representative image from a sheep assigned to the PREGNANT-CTRL group demonstrating a positive
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western blot result for both CD 81 and HSP 70 along with positive and negative controls. All biologic
replicates for each treatment group were positive for these surface markers.
3.4 Differential proteome content between treatment groups
Briefly, 539 proteins were identified as high confidence peptides. When high, medium and low
confidence peptides are considered the total number of identified proteins increases to 694. Figure A-12
depicts a volcano scatter plot representing the distribution of proteome data discovered with high
confidence between treatment groups. Twenty proteins identified were significantly abundant (P < 0.05)
between treatment groups. Table A-2 displays these significant proteins and the TMT ratios used in
estimating the relative concentration of each identified protein in samples. A fold-change threshold of 1.5
is used for up/down regulation, a TMT Ratio >1.5 is classified as up-regulated, and a ratio <0.67 is
classified as down- regulated. Ratios from 0.67 – 1.5 are considered moderate to no changes. Ratios
above 100 exceed the maximum allowed threshold that is reasonably expected. Pathway analysis
determined biological and cellular processes of proteins found to be differentially abundant based on
BVDV exposure; these are depicted in figure A-13 and A-14. Pathways associated with immunologic
processes, enzymatic regulation, protein binding and metabolic processes were upregulated in animals
exposed to BVDV. Notably, antioxidant activity, and catalytic activity, and defense responses were down
regulated with BVDV exposure.
4. Discussion
This study was successful in describing the proteome of circulating exosomes isolated from sheep
exposed to BVDV. Further, this is study is novel in describing the circulating exosomal proteome in
apparently healthy pregnant and non-pregnant sheep. Following successful isolation of circulating
exosomes, 539 proteins were identified with high confidence. To the authors’ knowledge, this is the first
description of the effects of viral reproductive pathogenesis on exosomal proteome profiles in livestock.
4.1 BVDV induces maternal-fetal pathology
Confirmation that BVDV infection was achieved following inoculation used a combination of
RT-PCR, IHC, and VN assay results. Observed histologic pathology was comprised of mild infiltration
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of white blood cells to the caruncular and intercaruncular tissue. However, no major histologic lesions
were observed in either pregnant and non-pregnant sheep infected with BVDV. BVDV NY-1 is a
relatively low virulence non-cytopathic strain of BVDV which accounts for the underwhelming amount
of histologic inflammation observed (Swasdipan et al., 2001). Perhaps the use of a more virulent strain of
BVDV would produce a more marked appearance of local tissue inflammation. BVDV antigen was
identified within the trophoblast in all pregnant sheep inoculated with the virus, confirming viral spread to
the fetal compartment by 15 dpi. Viral antigen was not identified at the caruncular tissue in non-pregnant
sheep infected with BVDV. BVDV is known to have a proclivity for reproductive tissue including the
fetal maternal interface and ovary (Fray, Mann, et al., 2000; Swasdipan et al., 2001). In non-pregnant
sheep blood supply to the caruncular tissue and local tissue immunity is vastly different compared to
pregnant sheep (Swasdipan et al., 2001). This inherent difference is tissue activity may have limited the
presence of viral replication at endometrium observed 15 dpi.
4.2 Exosomal proteins are differentially abundant based on viral exposure status
Many of the exosomal proteins identified are known to be associated with innate immunity and
inflammation, including fibrinogen and complement. Other than its role in coagulation, fibrinogen is an
acute phase protein produced by the liver during acute inflammation (Davalos & Akassoglou, 2012).
Several other acute phase proteins including haptoglobin, C-reactive protein, and serum amyloid A were
found to be abundant within BVDV exposure sheep yet significantly (data not shown). Complement
proteins are produced constitutively, yet production can be increased during inflammation (Daha & van
Kooten, 2016). These proteins aid in opsoninzation of antigens and direct killing of microbial pathogens
via complement complex formation. Other abundant proteins included proteins associated with the innate
immune arm such as immunoglobulin segments. Variable portions of immunoglobulins are upregulated in
pregnant BVDV inoculated animals compared to non-pregnant. B-lymphocytes are the producers of
circulating immunoglobulins. Further, this cell type are avid producers of exosomes during inflammation
(Saunderson & McLellan, 2017). The fact that the variable light chain was abundant without the presence
of the constant heavy chain indicated the smaller, antigen-binding portion of the immunoglobulins was
65

selectively being released. The presence of this profile of proteins supports a humoral immune response
following BVDV infection. The production of neutralizing antibodies is also supported by the VN titer
increase 30 days following experimental infection with BVDV. Concurrent peak viremia and viral
shedding of BVDV is expected to occur at 7 dpi, with resolution of viral shedding by 14 dpi (Grissett,
White, & Larson, 2015). This study looked at samples at 15 dpi, yet evidence of acute inflammation was
still present in the exosomal proteome of BVDV infected animals. In pregnant animals, the fetus and
trophoblast had confirmed presence of BVDV antigen, perhaps serving as a nidus of ongoing acute
inflammation.
Retinol binding protein 4 was down regulated in animals exposed to BVDV compared to
controls. Recent literature describes the role of retinol binding proteins inducing pro-inflammatory
response by T lymphocytes (Zabetian-Targhi, Mahmoudi, Rezaei, & Mahmoudi, 2015). It is interesting
that this protein would be down regulated in the face of induced inflammation associated with
experimental infection. Following acute BVDV, transient lymphopenia is observed 3-9 dpi, with
peripheral numbers recovering by 14 dpi (Falkenberg, Dassanayake, Neill, & Ridpath, 2017). BVDV has
a cellular tropism for lymphocytes and that cellular proclivity may thus interfere with lymphocyte
inflammatory response inducing immunosupression (Chase, Elmowalid, & Yousif, 2004; Howard, 1990).
The down regulation of this effector protein may represent a novel mechanism of immunosuppression
induced by BVDV infection.
Different forms of serpins were present and had a variable abundance pattern in BVDV infected
animals. Serpins are produced by the endometrium and appear to be progesterone dependent. Uterine
serpins’ mechanism of immune modulation during pregnancy was recently reviewed (Padua et al., 2005).
Serpin acts to down regulate immune cells, by inhibiting lymphocyte responses against the fetus, thus
inducing an anti-inflammatory environment at the maternal fetal interface during pregnancy (Liu,
Gottshall, & Hansen, 1997). The role of serpins during infectious placental pathology are less described.
One recent study described a negative association between Neospora caninum antibody titers and serpin
expression within the bovine placenta (Serrano-Perez et al., 2016). Furthermore, bovine uterine serpin
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concentrations are negatively correlated with interferon expression following N. caninum infection
(Serrano-Perez et al., 2018). In reproductive infection of naive cattle carrying fetuses transiently or
persistently infected with BVDV, interferon associated genes and interferon cytokines were elevated at
the maternal fetal interface and in maternal circulation compared to controls (Smirnova et al., 2014). With
the complex abundance pattern of serpins observed in this study, placental viral infection may disrupt the
immunosuppressive function of uterine serpin.
Several alpha-glycoproteins were up regulated in BVDV infected sheep. The binucleate
trophoblasts of pregnancy ruminants produce a variety of products including pregnancy-associated
glycoproteins (PAGs) (R. M. Wallace et al., 2015). Trophoblast are known to produce exosomes in many
species, indicating that PAGs may be present within these exosomes found in maternal circulation (Adam
et al., 2017; G. Burns et al., 2014). However, the predicted molecular structure of PAGs would need to
compared with the other glycoproteins discovered in this study to confirm this postulate. Histidine rich
glycoprotein was observed to be down regulated in pregnant sheep exposed to BVDV. Lower circulating
concentrations of this protein is associated with pre-eclampsia in women (Bolin, McClurkin, Cutlip, &
Coria, 1985). Exosome concentrations and content has been extensively investigated in human as
biomarkers to predict pre-eclampsia in women (Adam et al., 2017). Total numbers of circulating
exosomes is greater in pregnant woman compared to controls, yet pre-eclampic woman have 40% greater
exosomes than women with healthy pregnancies (Goswami et al., 2006). For this study, the total
concentration of exosomes was not determined between treatment groups.
Many forms of apolipoproteins were identified within treatment groups. This finding is expected
since the composition of exosomes is a lipid bilayer (Subra et al., 2010). In addition, the method of
isolated exosomes may yield other lipoprotein contamination from the lipid fraction of the blood (Karimi
et al., 2018). Apolipoprotein C III, which was downregulated in BVDV infected sheep, is active in the
peroxisome proliferator-activated receptors signaling pathway (PPAR) (Lui et al 2015). PPAR have been
demonstrated to play a significant role in human placentogenesis and a disruption of this signaling
pathway is thought to contribute to pathologic pregnancy conditions such as preeclampsia and intra67

uterine growth restriction (Ruebner et al., 2012). The dysregulation of this pathway is a possible novel
mechanism of BVDV-induced placental inflammation.
5. Conclusions
This is the first study profiling the proteome of exosomes isolated from pregnant and nonpregnant sheep exposed to BVDV. Differentially abundant proteins described in this study give insights
into novel mechanisms of immunosuppression and placental pathology not previously described with
BVDV infection. These data will serve future studies in helping to define placental immunity during
times of health and disease.
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Chapter 5
Conclusions
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Communication between the maternal and fetal tissues is critical for allow successful pregnancy.
This is supported by the exchange of proteins, nucleic acids, biologically active lipids at this interface at
the time of attachment and progression through a healthy gestation. The alteration of these compounds
are notable during times of pregnancy complications associated with infectious placental pathogenesis.
Further exploration of these maternal and fetal products is critical to gain a full understanding of the
milieu environment during healthy and disease pregnancy. After identification of markers associated with
feto-placental health and pathology, mechanisms of biologic activity can be elucidating using in-vitro and
in-vivo methodology. These data collected in this body of work serve as foundational research to answer
mechanistic questions of placental pathology. Furthermore, these works looked to identify biomarkers
associated with pathologic conditions that may be used to assess placental health during gestation.
These data presented are the first investigating alterations of maternal and fetal fluid PAG
concentrations following reproductive viral infection in ruminants. Our study supports that trophoblastic
injury associated with BVDV infection caused a significant decrease in PAG concentrations in maternal
circulation. This indicates that circulating PAG concentrations are a useful marker of placental function in
the BVDV infection and adds to the growing evidence that low PAG concentrations are correlated with
placental dysfunction and fetal loss with reproductive infections. Comparing PAG concentrations between
dams carrying PI and CI fetuses may demonstrate a pattern of trophoblastic injury through gestation.
Further characterization of the relationship between temporal PAG production using a fetal infection
model such as the viral model introduced here will yield future insights in evaluating these proteins as
biomarkers of the fetal-maternal unit. This is also the first study to compare PAG concentrations between
maternal jugular and venous blood. Further studies evaluating dilution or removal of PAG from systemic
circulation may elucidate sites beyond the uterine environment where PAG may exert novel function.
These were the first studies defining circulating exosomal content in pregnant and non-pregnant
animals exposed to a viral pathogen.. Many miRNAs identified our study are novel and not previously
described in livestock in reproductive viral infection and healthy pregnancy. Using the information
gleaned from this and publish work, a list of potential miRNAs that are biologically relevant during both
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healthy and pathology pregnancies can be created. Future studies using cell culture and infection models
like the one described here can help define the biologic impacts on trophoblasts and maternal cells. The
miRNAs described in this study may provide a useful resource for future investigators to further
characterize and select candidate miRNAs for further analysis for biological relevance. However, the
need for standardized methodology for miRNA isolation and annotation will better the current and future
databases allowing accurate available information. Defining the proteome of exosomes during pathologic
pregnancies is relatively novel, with few published reports to date. In our study, differentially abundant
proteins were discovered between infected and non-infected animals. This data gives insights into novel
mechanisms of immunosuppression and placental pathology not previously described with BVDV
infection. These data will serve future studies in helping to define placental immunity during times of
health and disease.
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ǂ

*
Figure 1:
Representative image of the maternal-fetal interface (placentome), BVDV inoculated animal, 80 days of
gestation. The chorioallantois (*) is lined by plump trophoblastic epithelium which is multifocally
immunopositive (arrows) for BVDV. The maternal endometrium (ǂ) interdigitates with the chorioallantois
and is lined by attenuated epithelium which does not exhibit immunopositivity for BVD.
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Figure 2:
Mean progesterone concentrations (ng/mL) (mean ± SEM) of control and BVDV inoculated ewes at
gestational day (GD) 80. No significant difference was determined, denoted as # (P = 0.08). SEM,
standard error of the mean.
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Figure 3:
Pearson’s correlation plots between progesterone and PAG1 concentrations between control (open
symbols) and BVDV (closed symbols) groups at GD 80. No significant correlation was observed (R2 =
0.0093).
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Figure 4:
Mean serum PAG1 concentration (ng/mL, mean ± SEM) of control and BVDV inoculated ewes at GD 65
and 80. Differences between gestational days (GD) denoted as # (P = 0.08) and * (P = 0.04). SEM,
standard error of the mean.
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Figure 5:
Mean uterine vein PAG1 concentration (ng/mL) (mean ± SEM) of control and BVDV inoculated ewes at
GD 80. Differences between treatment groups denoted as * (P = 0.01). SEM, standard error of the mean
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Figure 6:
Pearson’s correlation plots between uterine vein and jugular PAG1 concentrations between control
(closed symbols) and BVDV (open symbols) groups at GD 80. A significant correlation was observed
(R2 = 0.8, P < 0.01).

93

3.5

*

3

Progesterone ng/mL

2.5

2

1.5

1

0.5

0

PREGNANT-CTRL

PREGNANT-BVDV

NON PREGNANTCTRL

NON PREGNANTBVDV

Figure 7:
Mean progesterone concentrations (ng/mL) (mean ± SEM) of ewes from all treatment groups 15 dpi.
Mean progesterone concentrations for NON PREGNANT-BVDV group was significantly lower
compared to PREGNANT-CTRL (P = 0.01, denoted as *). No significant difference was determined
between other treatment groups. SEM, standard error of the mean.
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Figure 8:
Evaluation of isolated exosomes and associated miRNA. (A) representative western blot showing the
prescence of CD 81 and HSP 70, two characterized markers that define exosomes, isolated from a sheep
assigned to the PREGNANT – CTRL group along with positive (+) and negative (-) controls. (B) Agilent
electropherogram profiles of small RNAs extracted from circulating exosomes. The base pair length [nt]
(x axis) ploted against the fluorescence units [FU] (y axis). Note the clustering of RNA species below 60
base pair in all samples.

95

Figure 9:
Principle coordinate analysis illustrating degree of variance for miRNA abundance within each treatment
group.
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Figure 10:
Venn diagram representing number of differentially abundant miRNAs between treatment groups.
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Figure 11:
Representative western blot showing the presence of CD 81 and HSP 70, two characterized markers in
serum derived exosomes from a sheep assigned to the PREGNANT – CTRL group along with positive
(+) and negative (-) controls.
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Figure 12:
Volcano Plot showing proteomic data between pregnant versus non-pregnant sheep (A) as well as control
versus BVDV exposed sheep (B). The x-axis depicts large magnitude fold changes with statistical
significance (-log10 of p value) depicted on the y-axis. The plot is colored such that the points have a fold
change less than 2 (log2 =1) are shown in blue.
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Figure 13:
Pie chart representing down-regulated biologic and cellular processes from pathway analysis based on
BVDV exposure.
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Figure 14:
Pie chart representing upregulated biologic and cellular processes from pathway analysis based on BVDV
exposure.
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Table 1:
Most abundant circulating-exosome-derived miRNAs with differential abundance in sheep at 15 dpi.
Mean abundance for each treatment group is displayed as log count per million reads. Shading of counts
represents the quantity of reads (red = increased quantity, blue = decrease quantity).

bta-mir-10225b

Non-Pregnant,
BVDV
1.719024

Non-Pregnant,
CTRL
2.345936

Pregnant,
BVDV
1.719024

Pregnant,
CTRL
3.035236333

bta-mir-11998

5.078831

4.268056

4.779501

3.382291333

bta-mir-12022

8.028356

7.506199

7.784214

6.674143333

bta-mir-1291

2.213358

2.650805

3.615292

5.544595667

bta-mir-1388

3.969205

5.223099

5.747218

5.272334333

bta-mir-144

6.702682

7.192592

8.381197

7.924628667

bta-mir-187

1.866785

1.857453

3.304917

2.165693

bta-mir-193a

1.719024

2.289512

3.375086

2.788254

bta-mir-19a

2.829216

3.888565

4.998951

4.481507333

bta-mir-2330

2.213358

1.719024

2.861422

1.719024

bta-mir-2895

3.866853

3.124122

3.337584

2.255131667

bta-mir-29c

1.719024

1.964811

1.719024

2.838988333

bta-mir-34c

2.734612

2.942509

5.569437

3.891579

bta-mir-449c

2.734612

2.066833

3.170745

2.056786667

bta-mir-451

10.79098

11.29406

12.3562

11.95457633

bta-mir-767

3.760724

4.237765

3.398481

3.158994667

chi-mir-16a

3.693114

3.7939

5.393907

4.149750667

chi-mir-2284c

4.160002

4.827474

3.810683

3.591750333

chi-mir-29c

1.719024

1.857453

3.083628

2.056786667

hsa-mir-4453

1.866785

1.719024

2.059024

2.395147333

hsa-mir-4508

5.792865

4.48439

4.74379

4.442682

hsa-mir-5193

3.280715

2.638698

3.228549

1.719024

hsa-mir-6084

1.979656

1.719024

2.209571

2.724193

hsa-mir-6128

2.053924

2.54147

1.719024

2.451586667

hsa-mir-624

3.565997

1.914122

2.746937

1.991630333

mmu-mir-5106

8.924946

7.892783

8.743697

7.599069

mmu-mir-5119

7.6162

6.358208

7.318954

5.984148333

mmu-mir-5124a

3.196456

2.461247

2.753091

1.719024

mmu-mir-6368

2.510064

1.997888

3.885062

1.719024

miRNA
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Table 1 continued.
miRNA
mmu-mir-6990
mmu-mir-719
oar-mir-194
oar-mir-19b

Non-Pregnant,
BVDV
3.230875
3.351146
3.19406
5.035718

Non-Pregnant,
CTRL
2.861578
1.719024
3.389861
5.413829
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Pregnant,
BVDV
1.984056
3.129163
5.459918
6.307035

Pregnant,
CTRL
2.329991
2.629221667
3.490387
6.000914

Table 2:
Select circulating-exosome-derived proteins with differential abundance in sheep at 15 dpi. Mean
abundance is displayed as a ratio. Shading of counts represents the quantity of reads (red = increased
quantity, blue = decrease quantity).

Abundance Ratios
Protein

(BVDV) /
(CRTL)

(BVDV, NonPreg) /
(CRTL,Non-Preg)

(BVDV,Preg) /
(CRTL,Preg)

Alpha-1-acid glycoprotein
1

1.579

1.735

1.437

Alpha-1-antiproteinase

1.633

1.874

1.423

Alpha-2-HS-glycoprotein

0.283

0.333

0.241

Antithrombin-III

0.701

0.744

0.66

Apolipoprotein A-II

0.589

0.587

0.59

Apolipoprotein C-III

0.621

0.666

0.578

Complement factor Hrelated protein 2

0.653

0.655

0.651

Complement factor H

0.556

0.649

0.476

Fibrinogen alpha chain

0.639

0.628

0.651

Fibrinogen beta chain

0.66

0.623

0.7

Fibrinogen gamma chain

0.601

0.629

0.575

Histidine-rich glycoprotein

0.711

0.821

0.615

Immunoglobulin kappa2.1 light chain variable
region

1.419

1.288

1.564

1.397

1.535

1.273

Lumican

1.859

1.91

1.81

Retinol-binding protein 4

0.586

0.605

0.567

Serpin A3-5

2.181

2.711

1.755

Serpin A3-7

0.666

0.65

0.682

Immunoglobulin
light chain variable region
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Table 2 continued.

Abundance
Ratios
Protein
Transferrin receptor
protein 1
Zona pellucida spermbinding protein 3 receptor

(BVDV) /
(CRTL)

(BVDV, NonPreg) /
(CRTL,Non-Preg)

(BVDV,Preg) /
(CRTL,Preg)

2.007

1.721

2.34

0.46

0.479

0.442
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